U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Neurotransmitter Agents [Pharmacological Action]

Tree Number(s): D018377

MeSH Unique ID: D018377

  • alanyl-prolyl-glycyl-tryptophanamide (Supplementary Concept)
  • beta-Endorphin (MeSH Term)
  • Bombesin (MeSH Term)
  • Delta Sleep-Inducing Peptide (MeSH Term)
  • Dynorphins (MeSH Term)
  • Eledoisin (MeSH Term)
  • Endorphins (MeSH Term)
  • Enkephalin, Leucine (MeSH Term)
  • Enkephalin, Methionine (MeSH Term)
  • Enkephalins (MeSH Term)
  • Nitric Oxide (MeSH Term)
  • Physalaemin (MeSH Term)
  • Substance P (MeSH Term)
  • Kassinin (MeSH Term)
  • Neurokinin B (MeSH Term)
  • Neurokinin A (MeSH Term)
  • Tachykinins (MeSH Term)
  • alpha-Endorphin (MeSH Term)
  • gamma-Endorphin (MeSH Term)
  • Excitatory Amino Acids (MeSH Term)
  • Opioid Peptides (MeSH Term)
  • Enkephalin, Ala(2)-MePhe(4)-Gly(5)- (MeSH Term)
  • Enkephalin, D-Penicillamine (2,5)- (MeSH Term)
  • Pituitary Adenylate Cyclase-Activating Polypeptide (MeSH Term)
  • tramiprosate (Supplementary Concept)
  • brexanolone (Supplementary Concept)
  • tetrahydropalmatine (Supplementary Concept)
  • DSP 4 (Supplementary Concept)
  • lidamidine (Supplementary Concept)
  • dipivefrin (Supplementary Concept)
  • ST 91 (Supplementary Concept)
  • azepexole (Supplementary Concept)
  • amidephrine (Supplementary Concept)
  • anisodamine (Supplementary Concept)
  • indanidine (Supplementary Concept)
  • mivazerol (Supplementary Concept)
  • adrafinil (Supplementary Concept)
  • talipexole (Supplementary Concept)
  • norfenefrine (Supplementary Concept)
  • 2-cyclopentyl-4-phenylamino-1H-imidazo(4,5-c)quinoline (Supplementary Concept)
  • deterenol (Supplementary Concept)
  • 2-(4-bromo-2,5-dimethoxyphenyl)ethylamine (Supplementary Concept)
  • cirazoline (Supplementary Concept)
  • MH-76 compound (Supplementary Concept)
  • apraclonidine (Supplementary Concept)
  • 4-(1-(1-naphthyl)ethyl)imidazole (Supplementary Concept)
  • romifidine (Supplementary Concept)
  • lofexidine (Supplementary Concept)
  • detomidine (Supplementary Concept)
  • 3-nitrobiphenyline (Supplementary Concept)
  • tizanidine (Supplementary Concept)
  • amitraz (Supplementary Concept)
  • dibromophakellin (Supplementary Concept)
  • tulobuterol (Supplementary Concept)
  • Ro 363 (Supplementary Concept)
  • BRL 35135 (Supplementary Concept)
  • zinterol (Supplementary Concept)
  • ICI D7114 (Supplementary Concept)
  • rimiterol (Supplementary Concept)
  • amibegron (Supplementary Concept)
  • arbutamine (Supplementary Concept)
  • befunolol (Supplementary Concept)
  • denopamine (Supplementary Concept)
  • BRL 26830A (Supplementary Concept)
  • CGP 12177 (Supplementary Concept)
  • methoxyphenamine (Supplementary Concept)
  • mabuterol (Supplementary Concept)
  • bromoacetylalprenololmenthane (Supplementary Concept)
  • broxaterol (Supplementary Concept)
  • ractopamine (Supplementary Concept)
  • reproterol (Supplementary Concept)
  • dopexamine (Supplementary Concept)
  • cimaterol (Supplementary Concept)
  • BRL 37344 (Supplementary Concept)
  • higenamine (Supplementary Concept)
  • vanidipinedilol (Supplementary Concept)
  • LAS190792 (Supplementary Concept)
  • pirbuterol (Supplementary Concept)
  • 3-(4-((6-((-2-hydroxy-2-(4-hydroxy-3-(hydroxymethyl)phenyl)ethyl)amino)hexyl)oxy)butyl)benzenesulfonamide (Supplementary Concept)
  • vanidilol (Supplementary Concept)
  • AZD-3199 (Supplementary Concept)
  • bitolterol (Supplementary Concept)
  • disodium (R,R)-5-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxole-2,3-dicarboxylate (Supplementary Concept)
  • solabegron (Supplementary Concept)
  • 2-(2-chloro-4-(2-((2-hydroxy-2-(4-hydroxyphenyl)-1-methylethyl)amino)ethyl)phenoxy)acetic acid (Supplementary Concept)
  • ethyl 2-(2-chloro-4-(2-((2-hydroxy-2-(4-hydroxyphenyl)-1-methylethyl)amino)ethyl)phenoxy)acetate (Supplementary Concept)
  • ritobegron (Supplementary Concept)
  • N-(4-(2-((2-hydroxy-2-(3-pyridinyl)ethyl)amino)ethyl)phenyl)-4-(4-(4-(trifluoromethyl)phenyl)thiazol-2-yl)benzenesulfonamide (Supplementary Concept)
  • N-((4-((2-((2-hydroxy-2-(3-chlorophenyl)ethyl)amino)propyl)amino)phenyl)acetyl)-4-methylbenzenesulfonamide (Supplementary Concept)
  • N-((3-((2-((2-hydroxy-2-(3-chlorophenyl)ethyl)amino)propyl)amino)phenyl)acetyl)-4-methylbenzenesulfonamide (Supplementary Concept)
  • Amibegron hydrochloride (Supplementary Concept)
  • 4'-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)amino)ethyl)-3-methoxybiphenyl-4-carboxylic acid (Supplementary Concept)
  • mirabegron (Supplementary Concept)
  • ethyl 4-(4-((2-hydroxy-3-(4-hydroxy-3-((methylsulfonyl)amino)phenoxy)propyl)amino)cyclohexyl)benzoate (Supplementary Concept)
  • 4'-(2-((2-hydroxy-3-(4-hydroxyphenoxy)propyl)amino)ethyl)-2-(2-pyridyl)acetanilide (Supplementary Concept)
  • 4'-(2-((2-hydroxy-3-(4-hydroxyphenoxy)propyl)amino)ethyl)-2-(pyrimidin-2-yl)acetanilide (Supplementary Concept)
  • 4'-(2-((2-hydroxy-3-(4-hydroxyphenoxy)propyl)amino)ethyl)-2-(pyrazin-2-yl)acetanilide (Supplementary Concept)
  • profenamine (Supplementary Concept)
  • 1-(2-isopropoxyphenyl)-4-((2-oxopiperidin-1-yl)acetamido)propylpiperazine (Supplementary Concept)
  • BE 2254 (Supplementary Concept)
  • (2-(2',6'-dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane (Supplementary Concept)
  • ifenprodil (Supplementary Concept)
  • EEDQ (Supplementary Concept)
  • 1-benzylimidazole (Supplementary Concept)
  • BRL 44408 (Supplementary Concept)
  • naftopidil (Supplementary Concept)
  • dapiprazole (Supplementary Concept)
  • nipradilol (Supplementary Concept)
  • medroxalol (Supplementary Concept)
  • 1-(2-pyrimidinyl)piperazine (Supplementary Concept)
  • benalfocin (Supplementary Concept)
  • chlorethylclonidine (Supplementary Concept)
  • BMY 7378 (Supplementary Concept)
  • midaglizole (Supplementary Concept)
  • amosulalol (Supplementary Concept)
  • AR-C239 (Supplementary Concept)
  • SNAP 6201 (Supplementary Concept)
  • 5-carboxamido-1-(N-(3-(4-cyano-4-phenylpiperidin-1-yl)propyl)carboxamido)-6-(2,4-difluorophenyl)-4-ethyl-2-oxo-1,2,3,6-tetrahydropyrimidine (Supplementary Concept)
  • 1-(N-(3-(4-methyl-4-phenylpiperidin-1-yl)propyl)carboxamido)-6-(3,4-difluorophenyl)-5-methoxycarbonyl-4-methoxymethyl-2-oxo-1,2,3,6-tetrahydropyrimidine (Supplementary Concept)
  • bevantolol (Supplementary Concept)
  • 1,2,3,6-tetrahydro-1-(N-((4-(2-nitrophenyl)piperazin-1-yl)propyl)carboxamido)-4-methyl-6-(3,4-difluorophenyl)-2-oxopyrimidine (Supplementary Concept)
  • benextramine (Supplementary Concept)
  • phenylpiperazine (Supplementary Concept)
  • 3-(4-(1-(4-fluorophenyl)-5-(1-methyl-1,2,4-triazol-3-yl)-1H-indol-3-yl)-1-piperidinyl)propionitrile (Supplementary Concept)
  • arotinolol (Supplementary Concept)
  • SK and F 104078 (Supplementary Concept)
  • YM 12617 (Supplementary Concept)
  • 2-(beta-(3-iodo-4-hydroxyphenyl)ethylaminomethyl)tetralone (Supplementary Concept)
  • efaroxan (Supplementary Concept)
  • L 657743 (Supplementary Concept)
  • 5-methylurapidil (Supplementary Concept)
  • 2-methoxyidazoxan (Supplementary Concept)
  • proroxan (Supplementary Concept)
  • 7,8-(methylenedioxy)-14-hydroxyberbane (Supplementary Concept)
  • benoxathian (Supplementary Concept)
  • monatepil (Supplementary Concept)
  • 1-(3-(4-(o-tolyl)piperazin-1-yl)propyl)pyrrolidin-2-one (Supplementary Concept)
  • urapidil (Supplementary Concept)
  • bunazosin (Supplementary Concept)
  • ethyl 4-(3-(4-(2-methoxyphenyl)piperazinyl)propyl)aminoquinazolin-2-carboxylate (Supplementary Concept)
  • JTH 601 (Supplementary Concept)
  • Terazosin (Supplementary Concept)
  • RS 100329 (Supplementary Concept)
  • S 18327 (Supplementary Concept)
  • 4-(2-(2-methoxyphenoxy)ethylaminomethyl)-2,2-diphenyl(1,3)dioxolane (Supplementary Concept)
  • 4-(2-phenoxyethylaminomethyl)-2,2-diphenyl(1,3)dioxolane (Supplementary Concept)
  • 2-(2-(n-4-o-methoxyphenyl-N-1-piperazinyl)ethyl)-1-tetralone (Supplementary Concept)
  • 4-amino-5-(4-fluorophenyl)-6,7-dimethoxy-2-(4-(morpholinocarbonyl)--perhydro-1,4-diazepin-1-yl)quinoline (Supplementary Concept)
  • bucindolol (Supplementary Concept)
  • trimazosin (Supplementary Concept)
  • silodosin (Supplementary Concept)
  • alfuzosin (Supplementary Concept)
  • L 771688 (Supplementary Concept)
  • 6-(1-benzimidazolyl)-2-((4-(2-methoxyphenyl)piperazin-1-yl)butyl)pyridazin-3(2H)-one (Supplementary Concept)
  • 6-(imidazolyl)-2-((4-(2-chlorophenyl)piperazin-1-yl)heptyl)pyridazin-3(2H)-one (Supplementary Concept)
  • 6-(1-indolyl)-2-((4-(2-methoxyphenyl)piperazin-1-yl)butyl)pyridazin-3(2H)-one (Supplementary Concept)
  • 2-(3-(4-(2-isopropoxyphenyl)piperazin-1-yl)propyl)-3a,4,7,7a-tetrahydroisoindole-1,3-dione (Supplementary Concept)
  • N-(2-methyl-(4-indolyl-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexane carboxamide (Supplementary Concept)
  • 2-(3-fluorophenyl)-2,3-dihydro-N-(2-hydroxy-3-(4-(2-(1-methylethoxy)phenyl)-1-piperazinyl)propyl)-1,3-dioxo-1H-isoindole-5-carboxamide (Supplementary Concept)
  • 2-(4-methylphenyll)-2,3-dihydro-N-(2-hydroxy-3-(4-(2-(1-methylethoxy)phenyl)-1-piperazinyl)propyl)-1,3-dioxo-1H-isoindole-5-carboxamide (Supplementary Concept)
  • 8-((4-(2,5-dichlorophenyl)-1-piperazinyl)ethyl)-8-azaspiro(4,5)decane-7,9-dione (Supplementary Concept)
  • 8-(2-(4-(2,5-dichlorophenyl)-1-piperazinyl)ethyl)-8-azaspiro(4,5)dec-9,10-en-7-one (Supplementary Concept)
  • 8-(2-(4-(2,4,5-trifluorophenyl)piperazin-1-yl)ethyl)-8-azaspiro(4.5)decane-7,9-dione (Supplementary Concept)
  • 8-(2-(4-(2,4,5-trifluorophenyl)piperazin-1-yl)-1-methylethyl)-8-azaspiro(4.5)decane-7,9-dione (Supplementary Concept)
  • CP 93393 (Supplementary Concept)
  • 1-((imidazolidin-2-yl)imino)indazole (Supplementary Concept)
  • 1-((imidazolidin-2-yl)imino)-7-methylindazole (Supplementary Concept)
  • cyclazosin (Supplementary Concept)
  • atipamezole (Supplementary Concept)
  • N-(2-(4-(2,3-dihydrobenzo(1,4)dioxin-2-ylmethyl)-(1,4)diazepan-2-yl)ethyl)-2-phenoxynicotinamide (Supplementary Concept)
  • bufuralol (Supplementary Concept)
  • talinolol (Supplementary Concept)
  • indenolol (Supplementary Concept)
  • bopindolol (Supplementary Concept)
  • bufetolol (Supplementary Concept)
  • landiolol (Supplementary Concept)
  • tilisolol (Supplementary Concept)
  • butofilolol (Supplementary Concept)
  • 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (Supplementary Concept)
  • epanolol (Supplementary Concept)
  • ICI 89406 (Supplementary Concept)
  • tobanum (Supplementary Concept)
  • ICI 118551 (Supplementary Concept)
  • 3-iodopindolol (Supplementary Concept)
  • prizidilol (Supplementary Concept)
  • tertatolol (Supplementary Concept)
  • 5-hydroxypropafenone (Supplementary Concept)
  • cyanopindolol (Supplementary Concept)
  • carazolol (Supplementary Concept)
  • IPS 339 (Supplementary Concept)
  • mepindolol (Supplementary Concept)
  • flestolol (Supplementary Concept)
  • exaprolol (Supplementary Concept)
  • CGP 20712A (Supplementary Concept)
  • esmolol (Supplementary Concept)
  • 4-(2-hydroxy-3-isopropylaminopropoxy)-7-amino-6-iodofluorenone (Supplementary Concept)
  • 3-(2-ethylphenoxy)-1-(1,2,3,4-tetrahydronaphth-1-ylamino)-2-propanol oxalate (Supplementary Concept)
  • L 750355 (Supplementary Concept)
  • 2,3-dihydrothiopyrano(2,3-b)pyridine (Supplementary Concept)
  • 3,4-methylenedioxyethamphetamine (Supplementary Concept)
  • ethylphenidate (Supplementary Concept)
  • dibutylone (Supplementary Concept)
  • virodhamine (Supplementary Concept)
  • 1-pentyfluoro-1H-indole-3-carboxylic acid 8-quinolinyl ester (Supplementary Concept)
  • anandamide (Supplementary Concept)
  • palmidrol (Supplementary Concept)
  • N-oleoylethanolamine (Supplementary Concept)
  • 5F-APP-PICA (Supplementary Concept)
  • HU 308 (Supplementary Concept)
  • JHW 015 (Supplementary Concept)
  • naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone (Supplementary Concept)
  • 3-(5-dimethylcarbamoylpent-1-enyl)-N-(2-hydroxy-1-methylethyl)benzamide (Supplementary Concept)
  • lenabasum (Supplementary Concept)
  • arachidonoyl-2 chloroethanolamine (Supplementary Concept)
  • JWH-073 (Supplementary Concept)
  • AM 694 (Supplementary Concept)
  • (4-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone (Supplementary Concept)
  • 3-(2-nitro-1-phenylethyl)-2-phenyl-1H-indole (Supplementary Concept)
  • CB65 (Supplementary Concept)
  • iodopravadoline (Supplementary Concept)
  • glyceryl 2-arachidonate (Supplementary Concept)
  • 1-(4-chlorobutyl)-1,2-dihydro-N-(4-methylcyclohexyl)-2-oxo-1,8-naphthyridine-3-carboxamide (Supplementary Concept)
  • AM9405 (Supplementary Concept)
  • EG-018 (Supplementary Concept)
  • CB2 receptor agonist LY2828360 (Supplementary Concept)
  • N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide (Supplementary Concept)
  • cannabinoid receptor agonist 13 (Supplementary Concept)
  • THJ-2201 (Supplementary Concept)
  • methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamide)-3,3-dimethylbutanoate (Supplementary Concept)
  • LY 320135 (Supplementary Concept)
  • ibipinabant (Supplementary Concept)
  • surinabant (Supplementary Concept)
  • 192 IgG-saporin (Supplementary Concept)
  • bromantane (Supplementary Concept)
  • imidacloprid (Supplementary Concept)
  • subecholine (Supplementary Concept)
  • rimabotulinumtoxinB (Supplementary Concept)
  • botulinum toxin type D (Supplementary Concept)
  • abobotulinumtoxinA (Supplementary Concept)
  • incobotulinumtoxinA (Supplementary Concept)
  • furtrethonium (Supplementary Concept)
  • xanomeline (Supplementary Concept)
  • oxotremorine M (Supplementary Concept)
  • (S)-2-ethyl-8-methyl-1-thia-4,8-diazaspiro(4.5)decan-3-one (Supplementary Concept)
  • ethyl 3-(4-(6-fluoro-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl)pyrrolidine-1-carboxylate (Supplementary Concept)
  • CS 932 (Supplementary Concept)
  • 6-(4-butylthio-1,2,5-thiadiazol-3-yl)-1-azabicyclo(3.2.1)octane (Supplementary Concept)
  • cevimeline (Supplementary Concept)
  • TAK-071 (Supplementary Concept)
  • 3-(2,4-dimethoxybenzylidene)anabaseine (Supplementary Concept)
  • epibatidine (Supplementary Concept)
  • 3'-(5-chlorothiophen-2-yl)spiro-1-azabicyclo(2.2.2)octane-3,5'-(1',3')-oxazolidin-2'-one (Supplementary Concept)
  • N-(3-fluorobenzyl)-N-methylethanolamine (Supplementary Concept)
  • Donnatal (Supplementary Concept)
  • chlordiazepoxide, clidinium drug combination (Supplementary Concept)
  • triethylcholine (Supplementary Concept)
  • tofenacin (Supplementary Concept)
  • azatadine (Supplementary Concept)
  • desloratadine (Supplementary Concept)
  • phenglutarimide (Supplementary Concept)
  • glycopyrronium tosylate (Supplementary Concept)
  • temiverine (Supplementary Concept)
  • propiverine (Supplementary Concept)
  • trospium chloride (Supplementary Concept)
  • chlorphenoxamine (Supplementary Concept)
  • octotropine methylbromide (Supplementary Concept)
  • darifenacin (Supplementary Concept)
  • bornaprine (Supplementary Concept)
  • biperiden lactate (Supplementary Concept)
  • 4-diphenylacetoxy-1,1-dimethylpiperidinium (Supplementary Concept)
  • fesoterodine (Supplementary Concept)
  • diisopropyl(2-(3-(1-pyridin-2-ylethyl)-1H-inden-2-yl)ethyl)amine (Supplementary Concept)
  • caproctamine (Supplementary Concept)
  • 6-(ethyl-(2-methoxybenzyl)amino)hexanoic acid (8-((6-(ethyl-(2-methoxybenzyl)amino)hexanoyl)methylamino)octyl)methylamide (Supplementary Concept)
  • 8-benzyloxymethyl-3-ethoxycarbonyl-4-hydroxy-1-azabicyclo(3.3.1)non-3-ene (Supplementary Concept)
  • oxybutynin (Supplementary Concept)
  • octylonium (Supplementary Concept)
  • fencarbamide (Supplementary Concept)
  • emepronium carrageenate (Supplementary Concept)
  • hexahydrosiladifenidol (Supplementary Concept)
  • 1-((3,4-methylenedioxyphenyl)sulfonylphenyl)-1-(1-(1-(n-propylsulfonyl)morpholin-4-yl)morpholin-4-yl)dioxole (Supplementary Concept)
  • 1-((4-methoxyphenyl)sulfonylphenyl)-1(1-(1-(1-naphthylcarbonyl)morpholin-4-yl)morpholin-4-yl)dioxole (Supplementary Concept)
  • 1-((4-methoxyphenyl)sulfonylphenyl)-1-(1-(1-(4-fluoro-1-naphthylcarbonyl)morpholin-4-yl)morpholin-4-yl)dioxole (Supplementary Concept)
  • lithocholylcholine (Supplementary Concept)
  • 4-fluorohexahydrosiladifenidol (Supplementary Concept)
  • DA-8010 (Supplementary Concept)
  • delta-philanthotoxin (Supplementary Concept)
  • 1-hexanol (Supplementary Concept)
  • 3-(trifluoromethyl)-3-(3-iodophenyl)diazirine (Supplementary Concept)
  • alphaA-conotoxin OIVB, Conus obscurus (Supplementary Concept)
  • 4-((2-(1-methyl-2-pyrrolidinyl)ethyl)thio)phenol hydrochloride (Supplementary Concept)
  • N-n-decylnicotinium (Supplementary Concept)
  • 4-((3-trifluoromethyl)-3H-diazirin-3-yl)benzoylcholine (Supplementary Concept)
  • hexafluorenium (Supplementary Concept)
  • alpha-conotoxin MII (Supplementary Concept)
  • methyllycaconitine (Supplementary Concept)
  • acantoxin IVa, Acanthophis (Supplementary Concept)
  • 4-(6-heptenyl)-8-methylindolizidine (Supplementary Concept)
  • 4-allyl-8-ethylquinolizidine (Supplementary Concept)
  • 1,2,2a,5,5a,6,7,8,8a-nonahydro-4,6,8-trimethylquinolizino(1,8-ae)pyrrole (Supplementary Concept)
  • 2,2,6,6-tetramethylpiperidin-4-yl heptanoate (Supplementary Concept)
  • triethyl-(beta-4-stilbenoxyethyl)ammonium (Supplementary Concept)
  • MB408 (Supplementary Concept)
  • MB442 (Supplementary Concept)
  • MB444 (Supplementary Concept)
  • 2,5-hexanedione (Supplementary Concept)
  • normeperidine (Supplementary Concept)
  • phosalone (Supplementary Concept)
  • phoxim (Supplementary Concept)
  • demecarium (Supplementary Concept)
  • distigmine (Supplementary Concept)
  • 2-chloro-12-(2-piperidinoethyl)dibenzo(d,g)-1,3,6-dioxazocine (Supplementary Concept)
  • physostigmine heptyl (Supplementary Concept)
  • 1,10-phenanthroline (Supplementary Concept)
  • O,O'-(3-methyl)phenylenediphorylchloride (Supplementary Concept)
  • N,N'-(3-methyl)phenylenediaminophosphorylchloridate (Supplementary Concept)
  • (9-amino-5,6,7,8-tetrahydroacridin-4-yl)methanol (Supplementary Concept)
  • TZ2PA6 compound (Supplementary Concept)
  • Z 338 (Supplementary Concept)
  • AP 2238 (Supplementary Concept)
  • 14-norhuperzine A (Supplementary Concept)
  • velnacrine (Supplementary Concept)
  • methanesulfonyl fluoride (Supplementary Concept)
  • alternariol (Supplementary Concept)
  • N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine (Supplementary Concept)
  • fasciculin (Supplementary Concept)
  • phenserine (Supplementary Concept)
  • octamethyl pyrophosphoramide (Supplementary Concept)
  • 3-hydroxy-2-oxoindole (Supplementary Concept)
  • tabun (Supplementary Concept)
  • VX (Supplementary Concept)
  • huperzine A (Supplementary Concept)
  • 6,10,14-trimethylpentadeca-5,10-dien-2,12-dione (Supplementary Concept)
  • ethyl 5-amino-6,7,8,9-tetrahydro-2-methyl-4-phenylbenzo(1,8)naphthyridine-3-carboxylate (Supplementary Concept)
  • 6-(ethyl-(2-methoxybenzyl)amino)-1-(1'-(6-(ethyl-(2-methoxybenzyl)amino)hexanoyl)-(4,4')bipiperidinyl-1-yl)hexan-1-one (Supplementary Concept)
  • bis(18)-huperzine B (Supplementary Concept)
  • isosarcodine (Supplementary Concept)
  • N-(3-(1,2,3,4-tetrahydroacridin-9-ylamino)propyl)-N'-(4-(1,2,3,4-tetrahydroacridin-9-ylsulfanyl)butyl)acetamide (Supplementary Concept)
  • 3-methyl-2-(4-methyl-1-piperazinyl)-N-(7-((1,2,3,4-tetrahydroacridin-9-yl)amino)heptyl)quinoline-4-carboxamide (Supplementary Concept)
  • asoxime chloride (Supplementary Concept)
  • diacetylmonoxime (Supplementary Concept)
  • N,N'-monomethylenebis(pyridiniumaldoxime) (Supplementary Concept)
  • HLo 7 (Supplementary Concept)
  • pralidoxime (Supplementary Concept)
  • benserazide, levodopa drug combination (Supplementary Concept)
  • BAK4-54 (Supplementary Concept)
  • CAB2-015 (Supplementary Concept)
  • CE-123 (Supplementary Concept)
  • stepholidine (Supplementary Concept)
  • brexpiprazole (Supplementary Concept)
  • N-n-propyl-N-phenylethyl-4(3-hydroxyphenyl)ethylamine hydrochloride (Supplementary Concept)
  • fananserin (Supplementary Concept)
  • SK and F 82958 (Supplementary Concept)
  • alnespirone (Supplementary Concept)
  • NCQ 298 (Supplementary Concept)
  • A 68930 (Supplementary Concept)
  • ergocryptine (Supplementary Concept)
  • A 77636 (Supplementary Concept)
  • PD 158771 (Supplementary Concept)
  • dironyl (Supplementary Concept)
  • 3-N-methylspiperone (Supplementary Concept)
  • 1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine (Supplementary Concept)
  • docarpamine (Supplementary Concept)
  • 2-(N-phenethyl-N-propyl)amino-5-hydroxytetralin (Supplementary Concept)
  • naxagolide (Supplementary Concept)
  • preclamol (Supplementary Concept)
  • BP 897 (Supplementary Concept)
  • 7-hydroxy-2-N,N-dipropylaminotetralin (Supplementary Concept)
  • mesulergine (Supplementary Concept)
  • ibopamine (Supplementary Concept)
  • 1-(1-(2-benzo(b)thienyl)cyclohexyl)piperidine (Supplementary Concept)
  • dihydrexidine (Supplementary Concept)
  • 3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol (Supplementary Concept)
  • 3-((4-(4-chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine (Supplementary Concept)
  • ropinirole (Supplementary Concept)
  • quinagolide (Supplementary Concept)
  • rotigotine (Supplementary Concept)
  • quinelorane (Supplementary Concept)
  • CY 208-243 (Supplementary Concept)
  • N-(2-chloro-6-methylergoline-8-yl)-2,2-dimethylpropanamide (Supplementary Concept)
  • roxindole (Supplementary Concept)
  • N-n-propylnorapomorphine (Supplementary Concept)
  • carbidopa, levodopa drug combination (Supplementary Concept)
  • N-((4-(2-cyanophenyl)piperazinyl)methyl)benzamide (Supplementary Concept)
  • 2-(4-(2-cyanophenyl)-1-piperazinyl)-N-(3-methylphenyl) acetamide (Supplementary Concept)
  • SK and F 81297 (Supplementary Concept)
  • SK and F 77434 (Supplementary Concept)
  • PF-06669571 (Supplementary Concept)
  • ADTN (Supplementary Concept)
  • (3,4-dihydroxyphenylamino)-2-imidazoline (Supplementary Concept)
  • spiroxatrine (Supplementary Concept)
  • aceprometazine (Supplementary Concept)
  • FLB 457 (Supplementary Concept)
  • 1,2,3,4-tetrahydro-1-(phenylmethyl)isoquinoline (Supplementary Concept)
  • (5,6-dimethoxyindan-2-yl)dipropylamine (Supplementary Concept)
  • CP 293019 (Supplementary Concept)
  • VK4-116 (Supplementary Concept)
  • 7-methyl-2,3-dimethoxy-5,6,7,8,9,14-hexahydrodibenz(d,g)azecine (Supplementary Concept)
  • 4-hydroxy-1-methyl-4-(4-methylphenyl)-3-piperidyl 4-methylphenyl ketone (Supplementary Concept)
  • 7-methyl-6,7,8,9,14,15-hexahydro-5H-benz(d)indolo(2,3-g)azecine (Supplementary Concept)
  • nemonapride (Supplementary Concept)
  • 3-(2-(4-((3-(3-(5-methyl-1,2,4-oxadiazolyl))phenyl)carboxamido)cyclohexyl)ethyl)-7-methylsulfonyl-2,3,4,5-tetrahydro-1H-benzazepine (Supplementary Concept)
  • 3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide (Supplementary Concept)
  • 1H-3-benzazepin-7-ol, 8-bromo-2,3,4,5-tetrahydro-3-methyl-5-phenyl- (Supplementary Concept)
  • UH 232 (Supplementary Concept)
  • eticlopride (Supplementary Concept)
  • N-(2-((bis(4-fluorophenyl)methyl)thio)ethyl)-3-phenylpropan-1-amine (Supplementary Concept)
  • S-phenylpiracetam (Supplementary Concept)
  • bromopride (Supplementary Concept)
  • ziprasidone (Supplementary Concept)
  • nafadotride (Supplementary Concept)
  • flupenthixol decanoate (Supplementary Concept)
  • CI 1030 (Supplementary Concept)
  • FAUC 346 (Supplementary Concept)
  • FAUC 365 (Supplementary Concept)
  • ecopipam (Supplementary Concept)
  • 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (Supplementary Concept)
  • 8-iodo-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepine-7-ol (Supplementary Concept)
  • 1-methyl-1,2,3,4-tetrahydroisoquinoline (Supplementary Concept)
  • 5-methoxy-1-methyl-2-(n-propylamino)tetralin (Supplementary Concept)
  • mesdopetam (Supplementary Concept)
  • 3-(4-(4-chlorophenyl-4-hydroxypiperidino)methyl)indole (Supplementary Concept)
  • GR 103691 (Supplementary Concept)
  • 1-(2-ethoxyphenyl)-4-(3-(3-thiophen-2-ylisoxazolin-5-yl)propyl)piperazine (Supplementary Concept)
  • S 18126 (Supplementary Concept)
  • NGB 2849 (Supplementary Concept)
  • 3-(4-(4-chlorophenyl)piperazinylmethyl)pyrazolo(1,5-a)pyridine (Supplementary Concept)
  • mazapertine succinate (Supplementary Concept)
  • 1-methyl-3-(2-(4-phenylbutyl)phenoxymethyl)piperidine (Supplementary Concept)
  • 1-ethyl-3-(2-(4-(3-methoxyphenyl)butyl)phenoxymethyl)piperidine (Supplementary Concept)
  • 1-methyl-3-(2-(4-(3-methoxyphenyl)butyl)phenoxymethyl)piperidine (Supplementary Concept)
  • 8-(4-(3-(5-fluoro-1H-indol-3-yl)propyl)piperazin-1-yl)-4H-benzo(1,4)oxazin-2-methyl-3-one (Supplementary Concept)
  • 2-((benzyl)propylamino)-5-methoxytetralin (Supplementary Concept)
  • 9-(4-methylpiperazin-1-yl)pyrrolo(2,1-b)benzothiazepine (Supplementary Concept)
  • 1H-indole-2-carboxylic acid (4-(2-(cyano-3,4-dihydro-1H-isoquinolin-2-yl)ethyl)cyclohexyl)amide (Supplementary Concept)
  • fallypride (Supplementary Concept)
  • N-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine (Supplementary Concept)
  • CLR151 (Supplementary Concept)
  • 1-((2-phenylcyclopropyl)methyl)-4-(2,4-dichlorophenyl)piperazine (Supplementary Concept)
  • 1-((2-phenylcyclopropyl)-methyl)-4-(2,4-dimethylphenyl)piperazine (Supplementary Concept)
  • 2-amino-2,3,3a,4,5,6-hexahydro-1H-phenalene (Supplementary Concept)
  • 5-bromo-N-(1-ethyl-4-methylhexahydro-1H-1,4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridinecarboxamide 2-fumarate (Supplementary Concept)
  • N-((2,2-dimethyl-2,3-dihydrobenzofuran-7-yloxy)ethyl)-3-(cyclopent-1-enyl)benzylamine (Supplementary Concept)
  • YKP 1358 (Supplementary Concept)
  • 3-(3-(methylsulfonyl)phenyl)-1-propylpiperidine (Supplementary Concept)
  • 1-((5-methoxy-1H-indol-3-yl)methyl)-4-(4-(methylthio)phenyl)piperidin-4-ol (Supplementary Concept)
  • (1R-(exo,exo))-3-(4-fluorophenyl)-8-methyl-8- azabicyclo(3.2.1)octane-2-carboxylic acid, methyl ester (Supplementary Concept)
  • vanoxerine (Supplementary Concept)
  • 1-(2 (diphenylmethoxy)ethyl)-4-(3-phenylpropyl)piperazine (Supplementary Concept)
  • cocaethylene (Supplementary Concept)
  • avermectin (Supplementary Concept)
  • (alpha-carboxycyclopropyl)glycine (Supplementary Concept)
  • 3,5-dihydroxyphenylglycine (Supplementary Concept)
  • UBP684 (Supplementary Concept)
  • UBP753 (Supplementary Concept)
  • 2-amino-4-phosphonobutyric acid (Supplementary Concept)
  • 1-hydroxy-3-amino-2-pyrrolidone (Supplementary Concept)
  • beta-N-methylamino-L-alanine (Supplementary Concept)
  • LSP2-9166 (Supplementary Concept)
  • eglumetad (Supplementary Concept)
  • 2-chloro-5-hydroxyphenylglycine (Supplementary Concept)
  • 2-amino-3-(3-(carboxymethoxy)-5-tert-butyl-4-isoxazolyl)propionic acid (Supplementary Concept)
  • 2-amino-4-carboxy-7-(2-naphthyl)hept-6-enoic acid (Supplementary Concept)
  • 2-amino-3-phosphonopropionic acid (Supplementary Concept)
  • 2-amino-3-((3,4-difluorophenyl)sulfanylmethyl)-4-hydroxy-bicyclo(3.1.0)hexane-2,6-dicarboxylic acid hydrochloride (Supplementary Concept)
  • conantokin-T (Supplementary Concept)
  • CGP 39653 (Supplementary Concept)
  • gacyclidine (Supplementary Concept)
  • 4-trans-2-carboxy-5,7-dichloro-4-phenylaminocarbonylamino-1,2,3,4-tetrahydroquinoline (Supplementary Concept)
  • 2-amino-4-methyl-5-phosphono-3-pentenoic acid (Supplementary Concept)
  • CGP 39551 (Supplementary Concept)
  • SDZ EAA 494 (Supplementary Concept)
  • 6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione (Supplementary Concept)
  • LY 235959 (Supplementary Concept)
  • selfotel (Supplementary Concept)
  • 6-methyl-2-(phenylethynyl)pyridine (Supplementary Concept)
  • 2,3-piperidinedicarboxylic acid (Supplementary Concept)
  • 2-amino-7-phosphonoheptanoic acid (Supplementary Concept)
  • conotoxin GV (Supplementary Concept)
  • FG 9041 (Supplementary Concept)
  • NPC 12626 (Supplementary Concept)
  • GYKI 52466 (Supplementary Concept)
  • HU 211 (Supplementary Concept)
  • 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline (Supplementary Concept)
  • GYKI 53655 (Supplementary Concept)
  • 4-carboxyphenylglycine (Supplementary Concept)
  • alpha-methyl-4-carboxyphenylglycine (Supplementary Concept)
  • aptiganel (Supplementary Concept)
  • licostinel (Supplementary Concept)
  • L 701324 (Supplementary Concept)
  • 1-aminoindan-1,5-dicarboxylic acid (Supplementary Concept)
  • kaitocephalin (Supplementary Concept)
  • 7-chlorokynurenic acid (Supplementary Concept)
  • eliprodil (Supplementary Concept)
  • carbinoxamine, dextromethorphan, pseudoephedrine drug combination (Supplementary Concept)
  • 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid (Supplementary Concept)
  • caroverine (Supplementary Concept)
  • 2-Oxo-PCE (Supplementary Concept)
  • phetharbital (Supplementary Concept)
  • 2-(1,1-dimethyl-1,3-dihydro-benzo(e)indol-2-ylidene)-malonaldehyde (Supplementary Concept)
  • BCI-838 (Supplementary Concept)
  • 3-(2-((phenylamino)carbonyl)ethenyl)-4,6-dichloroindole-2-carboxylic acid (Supplementary Concept)
  • LY 341495 (Supplementary Concept)
  • 5,7-dichlorokynurenic acid (Supplementary Concept)
  • glutamic acid diethyl ester (Supplementary Concept)
  • ketobemidone (Supplementary Concept)
  • phenazepam (Supplementary Concept)
  • N-(4,4-diphenyl-3-butenyl)nipecotic acid (Supplementary Concept)
  • gaboxadol (Supplementary Concept)
  • progabide (Supplementary Concept)
  • 2-phenylpyrazolo(4,3-c)quinolin-3(5H)-one (Supplementary Concept)
  • ethyl 6-benzyloxy-beta-carboline-3-carboyxlate (Supplementary Concept)
  • piperidine-4-sulfonic acid (Supplementary Concept)
  • adipiplon (Supplementary Concept)
  • 3-aminopropylphosphinic acid (Supplementary Concept)
  • isoguvacine (Supplementary Concept)
  • 4-amino-3-phenylbutyric acid (Supplementary Concept)
  • 6,6-dimethyl-3-(2-hydroxyethyl)thio-1-(thiazol-2-yl)-6,7-dihydro-2-benzothiophen-4(5H)-one (Supplementary Concept)
  • NNC 14-0185 (Supplementary Concept)
  • NNC 14-0189 (Supplementary Concept)
  • 3-(5-cyclopropyl-1,2,4-oxadiazol-3-yl) 7-bromo-5,6-dihydro-5-methyl-6-oxo-4H-imidazo(1,5.alpha)-benzodiazepine (Supplementary Concept)
  • 9-chloro-7-(2-chlorophenyl)-5H-pyrimido(5,4-d)(2)benzazepine (Supplementary Concept)
  • 1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydroimidazol-2-one (Supplementary Concept)
  • 3-amino-2-fluoropropylsulfinic acid (Supplementary Concept)
  • N,N-dimethyl-(2-(4-methylphenyl)-5-methylpyrazolo(1,5-a)pyrimidin-3-yl)acetamide (Supplementary Concept)
  • L 838,417 (Supplementary Concept)
  • 6,3'-dibromoflavone (Supplementary Concept)
  • 6-nitro-3'-bromoflavone (Supplementary Concept)
  • 3'-(5-(1-hydroxy-1-methylethyl)benzoimidazol-1-yl)biphenyl-2-carbonitrile (Supplementary Concept)
  • 3-phenyl-6-(2-pyridyl)methoxy-7,8,9,10-tetrahydro(7,10-ethano)-1,2,4-triazolo(3,4-a)phthalazine (Supplementary Concept)
  • N-(3-fluoro-4-(2-(propylamino)ethoxy)phenyl)-4,5,6,7-tetrahydro-4-oxo-1H-indole-3-carboxamide (Supplementary Concept)
  • deschloroetizolam (Supplementary Concept)
  • abp-700 (Supplementary Concept)
  • N-(p-methylbenzyl)-5-nitroindol-3-ylglyoxylamide (Supplementary Concept)
  • 7-chloro-5((cis-3,5-dimethylpiperazine)carbonyl)imidazo(1,5a)quinoline-3-carboxylate (Supplementary Concept)
  • lesogaberan (Supplementary Concept)
  • 7-cyclobutyl-6-(2-methyl-2H-1,2,4-triazol-3-ylmethoxy)-3-phenyl-1,2,4-triazolo(4,3-b)pyridazine (Supplementary Concept)
  • 2-methoxy-3,8,9-trihydroxy coumestan (Supplementary Concept)
  • 9-chloro-2-phenyl-(1,2,3)triazolo(1,2-a)(1,2,4)benzotriazin-1,5(6H)-dione (Supplementary Concept)
  • 3-amino-2-(S)-hydroxypropyl-methyl-phosphinic acid (Supplementary Concept)
  • 2,6-di-tert-butyl-4-(3-hydroxy-2,2-dimethylpropyl)phenol (Supplementary Concept)
  • CGP 13501 (Supplementary Concept)
  • arbaclofen placarbil (Supplementary Concept)
  • FG 7142 (Supplementary Concept)
  • CGP 55845A (Supplementary Concept)
  • NNC 711 (Supplementary Concept)
  • (3-aminopropyl)(n-butyl)phosphinic acid (Supplementary Concept)
  • bicuculline methochloride (Supplementary Concept)
  • phaclofen (Supplementary Concept)
  • RU 5135 (Supplementary Concept)
  • ZK 93426 (Supplementary Concept)
  • KN 244 (Supplementary Concept)
  • saclofen (Supplementary Concept)
  • gabazine (Supplementary Concept)
  • CGP 35348 (Supplementary Concept)
  • 5-hydroxysaclofen (Supplementary Concept)
  • 1,3-bis(8-ethynyl-5,6-dihydro-5-methyl-6-oxo-4H-imidazo(1,5-a)(1,4)benzodiazepine-3-carboxy)propyl diester (Supplementary Concept)
  • picrotoxinin (Supplementary Concept)
  • S44819 (Supplementary Concept)
  • fipronil sulfone (Supplementary Concept)
  • 17-phenylandrost-16-en-3-ol (Supplementary Concept)
  • 6-bromo-3'-nitroflavone (Supplementary Concept)
  • 3-aminopropyl-P-(alpha-hydroxybenzyl)phosphinic acid (Supplementary Concept)
  • 3-aminopropyl-(1,1,-difluoro-n-butyl)phosphinic acid (Supplementary Concept)
  • CGP 47332A (Supplementary Concept)
  • 2-hydroxysaclofen (Supplementary Concept)
  • 3-amino-2-hydroxypropylcyclohexylmethylphosphinic acid (Supplementary Concept)
  • CGP 71872 (Supplementary Concept)
  • 2-hydroxy-2-(4'-chlorophenyl)butyramide (Supplementary Concept)
  • 3-hydroxy-3-(4'-chlorophenyl)pentanamide (Supplementary Concept)
  • 4-hydroxy-4-(4'-chlorophenyl)hexanamide (Supplementary Concept)
  • SGE-872 (Supplementary Concept)
  • nimetazepam (Supplementary Concept)
  • zaleplon (Supplementary Concept)
  • imidazenil (Supplementary Concept)
  • indiplon (Supplementary Concept)
  • PF-06372865 (Supplementary Concept)
  • ganaxolone (Supplementary Concept)
  • amobarbital, secobarital drug combination (Supplementary Concept)
  • ASP8062 (Supplementary Concept)
  • SGE-102 (Supplementary Concept)
  • pyrazolam (Supplementary Concept)
  • CI 966 (Supplementary Concept)
  • histamine phosphate (Supplementary Concept)
  • alpha-methylhistamine (Supplementary Concept)
  • imetit (Supplementary Concept)
  • 2-(2-aminoethyl)pyridine (Supplementary Concept)
  • 2-(2-(3-(3-fluorophenyl)-3-phenylpropyl)-1H-imidazol-4-yl)ethanamine (Supplementary Concept)
  • 2-(2-aminoethyl)thiazole (Supplementary Concept)
  • 2-(2-aminoethyl)-1-(1H-imidazol-4-yl)cyclopropane (Supplementary Concept)
  • SK and F 91488 (Supplementary Concept)
  • 4-(imidazol-4-ylmethyl)-1-methylpiperidine (Supplementary Concept)
  • 4-(4-methyl-3-pyrrolidinyl)-1H-imidazole dihydrochloride (Supplementary Concept)
  • traxanox (Supplementary Concept)
  • bamipine (Supplementary Concept)
  • suplatast tosilate (Supplementary Concept)
  • ozagrel (Supplementary Concept)
  • thonzylamine (Supplementary Concept)
  • AQ 0145 (Supplementary Concept)
  • nitrophorin (Supplementary Concept)
  • toreforant (Supplementary Concept)
  • (2-(2-(2-methylpyrrolidin-1-yl)ethyl)benzofuran-5-yl)(5-nitropyridin-2-yl)amine (Supplementary Concept)
  • GR 190028 (Supplementary Concept)
  • FUB 271 (Supplementary Concept)
  • N-(4-chlorobenzyl)-N-(7-pyrrolidin-1-ylheptyl)guanidine (Supplementary Concept)
  • N-(4-chlorobenzyl)-N-(6-pyrrolidin-1-ylhexyl)guanidine (Supplementary Concept)
  • imoproxifan (Supplementary Concept)
  • 4-((3-(4-(2-aminopropanoyl)-1-piperazinyl)propoxy)phenyl)cyclopropylmethanone (Supplementary Concept)
  • SCH 79687 (Supplementary Concept)
  • 1-(4-(3-piperidin-1-ylpropoxy)benzyl)piperidine (Supplementary Concept)
  • pemirolast (Supplementary Concept)
  • tesmilifene (Supplementary Concept)
  • repirinast (Supplementary Concept)
  • quifenadine (Supplementary Concept)
  • 4-(1-cyclohexylpentanoyl-4-piperidyl)-1H-imidazole (Supplementary Concept)
  • isothipendyl (Supplementary Concept)
  • buclizine (Supplementary Concept)
  • proxyfan (Supplementary Concept)
  • 3-(1H-imidazol-4-yl)propyl N-(1,2,2-trimethylpropyl) carbamate (Supplementary Concept)
  • brompheniramine maleate, pseudoephedrine sulfate drug combination (Supplementary Concept)
  • benzonitrile, 4-(2-(2-((2r)-2-methyl-1-pyrrolidinyl)ethyl)-5-benzofuranyl)- (Supplementary Concept)
  • 4-(6-cyclohexylhex-3-enyl)imidazole (Supplementary Concept)
  • 4-(2-(5,5-dimethylhex-1-ynyl)cyclopropyl)imidazole (Supplementary Concept)
  • 4-(piperazin-1-yl)-8-(trifluoromethyl)pyrido(2,3-e)(1,2,4) triazolo(4,3-a)pyrazine (Supplementary Concept)
  • tritoqualine (Supplementary Concept)
  • dexchlorpheniramine (Supplementary Concept)
  • proxicromil (Supplementary Concept)
  • doxylamine succinate (Supplementary Concept)
  • fonazine (Supplementary Concept)
  • dibenzheptropine (Supplementary Concept)
  • embramine (Supplementary Concept)
  • mequitazine (Supplementary Concept)
  • pseudoephedrine, triprolidine drug combination (Supplementary Concept)
  • NCO 650 (Supplementary Concept)
  • epinastine (Supplementary Concept)
  • azatadine maleate, pseudoephedrine sulfate drug combination (Supplementary Concept)
  • isospaglumic acid (Supplementary Concept)
  • trimeprazine tartrate (Supplementary Concept)
  • histabudifen (Supplementary Concept)
  • histapendifen (Supplementary Concept)
  • lodoxamide tromethamine (Supplementary Concept)
  • dicyclomine, doxylamine, pyridoxine drug combination (Supplementary Concept)
  • carbinoxamine (Supplementary Concept)
  • chloropyramine (Supplementary Concept)
  • phenindamine (Supplementary Concept)
  • emedastine (Supplementary Concept)
  • alcaftadine (Supplementary Concept)
  • dexbrompheniramine (Supplementary Concept)
  • oxatomide (Supplementary Concept)
  • picumast (Supplementary Concept)
  • ebastine (Supplementary Concept)
  • carebastine (Supplementary Concept)
  • protopine (Supplementary Concept)
  • temelastine (Supplementary Concept)
  • chlorpheniramine, ephedrine drug combination (Supplementary Concept)
  • 5,6-dihydrospiro(11H-imidazo(2,1-b)(3)benzazepine-11,4'-piperidine)-3-carboxamide (Supplementary Concept)
  • tranilast (Supplementary Concept)
  • azelastine (Supplementary Concept)
  • mizolastine (Supplementary Concept)
  • levocetirizine (Supplementary Concept)
  • acrivastine (Supplementary Concept)
  • fexofenadine (Supplementary Concept)
  • levocabastine (Supplementary Concept)
  • ranitidine bismuth citrate (Supplementary Concept)
  • ebrotidine (Supplementary Concept)
  • lafutidine (Supplementary Concept)
  • etintidine (Supplementary Concept)
  • mifentidine (Supplementary Concept)
  • roxatidine acetate (Supplementary Concept)
  • SK and F 93479 (Supplementary Concept)
  • loxtidine (Supplementary Concept)
  • tiotidine (Supplementary Concept)
  • zolantidine (Supplementary Concept)
  • TZU 0460 (Supplementary Concept)
  • oxmetidine (Supplementary Concept)
  • 3-(1'-cyclobutylspiro(4H-1,3-benzodioxine-2,4'-piperidine)-6-yl)-5,5-dimethyl-1,4-dihydropyridazin-6-one (Supplementary Concept)
  • clobenpropit (Supplementary Concept)
  • iodophenpropit (Supplementary Concept)
  • thioperamide (Supplementary Concept)
  • N-(2-(4-(3-(4-(cyclopropylcarbonyl)phenoxy)propyl)-1-piperazinyl)-1-methyl-2-oxoethyl)-2-furamide (Supplementary Concept)
  • ciproxifan (Supplementary Concept)
  • histamine H3R antagonist 2-18 (Supplementary Concept)
  • 7,7-diphenyl-2-(1-imino-2-(2-methoxyphenyl)ethyl)perhydroisoindol-4-one (Supplementary Concept)
  • cyclo((2-naphthyl)alanyl-tryptophyl-(4-fluoro)phenylalanyl-threonyl-phenylalanyl-prolyl) (Supplementary Concept)
  • LY 306740 (Supplementary Concept)
  • MEN 10930 (Supplementary Concept)
  • MDL 108,207DA (Supplementary Concept)
  • YM 35375 (Supplementary Concept)
  • substance P, Arg(1)-Pro(2)-Phe(7)-His(9)- (Supplementary Concept)
  • CI 1021 (Supplementary Concept)
  • SDZ NKT 343 (Supplementary Concept)
  • HSP 117 (Supplementary Concept)
  • R116301 (Supplementary Concept)
  • MDL 103392 (Supplementary Concept)
  • 2-(1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluoro)phenyl-4-(5-(2-phosphoryl-3-oxo-4H,-1,2,4-triazolo))methylmorpholine, bis(N-methylglucamine) salt (Supplementary Concept)
  • casopitant (Supplementary Concept)
  • N-((2-cyclopropoxy-5-(5-trifluomethyl)tetrazol-1-yl)benzyl)-2-phenylpiperidin-3-amine (Supplementary Concept)
  • 3-(6-methoxy-1-methyl-1-trifluoromethylisochroman-7-yl)methylamino-2-phenylpiperidine (Supplementary Concept)
  • 6-diphenylmethyl-5-(5-isopropyl-2-methoxybenzylamino)-1-azabicyclo(2.2.2)octane-3-carboxylic acid (Supplementary Concept)
  • serlopitant (Supplementary Concept)
  • tyrosyl-cyclo(penicillamine-glycyl-phenylalanyl-penicillamine)-prolyl-leucyl-tryptophyl-NH-(3',5'-(CF3)2-Bzl) (Supplementary Concept)
  • 2-piperazin-1-ylindan-2-carboxylic acid (3-chloro-5-fluorobenzyl)methylamide (Supplementary Concept)
  • AZD 8081 (Supplementary Concept)
  • AZD 2738 (Supplementary Concept)
  • 1-(amino(oxo)acetyl)-N-(1-(3,5-bis(trifluoromethyl)phenyl)ethyl)-3-(4-fluoro-2-methylphenyl)-N-methylpiperidine-4-carboxamide (Supplementary Concept)
  • rolapitant (Supplementary Concept)
  • fosaprepitant (Supplementary Concept)
  • FK886 (Supplementary Concept)
  • 1-(N-(2-methoxybenzyl)acetylamino)-3-(1H-indol-3-yl)-2-(N-(2-(4-(piperidin-1-yl)piperidin-1-yl)acetyl)amino)propane (Supplementary Concept)
  • (2-methoxy-5-tetrazol-1-ylbenzyl)(2-phenylpiperidin-3-yl)amine (Supplementary Concept)
  • S 16474 (Supplementary Concept)
  • MDL 105212A (Supplementary Concept)
  • quinoline-4-carboxylic acid (1-(3,5-bis-trifluoromethylbenzoyl)-2-(4-chlorobenzyl)piperidin-4-yl)amide (Supplementary Concept)
  • 3-aryl-6-phenyl-1-oxa-7-azaspiro(4.5)decane (Supplementary Concept)
  • 1-oxo-7-azaspirodecane (Supplementary Concept)
  • PD 174424 (Supplementary Concept)
  • 6-phenyl-1-oxa-7-azaspiro(4,5)decane (Supplementary Concept)
  • vestipitant (Supplementary Concept)
  • Sch 425078 (Supplementary Concept)
  • (2-fluoromethoxy-5-(5-trifluoromethyltetrazol-1-yl)benzyl)(2-phenylpiperidin-3-yl)amine (Supplementary Concept)
  • tyrosyl-alanyl-glycyl-phenylalanyl-methionyl-prolyl-leucyl-tryptophyl-O-3,5-benzyl(CF3)2 (Supplementary Concept)
  • tyrosyl-alanyl-glycyl-phenylalanyl-norleucyl-prolyl-leucyl-tryptophyl-O-3,5-benzyl(CF3)2 (Supplementary Concept)
  • S 18523 (Supplementary Concept)
  • vofopitant (Supplementary Concept)
  • CAM 4515 (Supplementary Concept)
  • CAM 4750 (Supplementary Concept)
  • 3-((3,5-bis(trifluoromethyl)phenyl)methyloxy)-2-phenylpiperidine (Supplementary Concept)
  • L 741671 (Supplementary Concept)
  • L 743310 (Supplementary Concept)
  • ASN 1377642 (Supplementary Concept)
  • 3-(2-methoxy-5-trifluoromethoxybenzyl)amino-1-methyl-2-phenylpiperidine (Supplementary Concept)
  • N-(3,5-bis(trifluoromethyl)benzyl)-7,8-dihydro-N,7-dimethyl-5-(4-methylphenyl)-8-oxo-1,7-naphthyridine-6-carboxamide (Supplementary Concept)
  • N-(1-(3,5-bis(trifluoromethyl)phenyl)ethyl)-7,8-dihydro-N,7-dimethyl-5-(4-methylphenyl)-8-oxo-1,7-naphthyridine-6-carboxamide (Supplementary Concept)
  • 1-(4-(3,5-bis(trifluoromethyl)benzyloxymethyl)-4-phenylpiperidin-1-yl)-2-pyrrolidineacetamide (Supplementary Concept)
  • 4-(3,5-bis(trifluoromethyl)benzyloxymethyl)-1-(2-methylthiazol-5-ylmethyl)-4-phenylpiperidine (Supplementary Concept)
  • minaxolone (Supplementary Concept)
  • hydroxydione (Supplementary Concept)
  • alphaxalone (Supplementary Concept)
  • alphadolone (Supplementary Concept)
  • O(3alpha)-,O(21)-di-(N(1)-methyloxycarbonyl-2, 4-dioxo-5-fluoropyrimidinyl)-17alpha-hydroxy-5beta-pregnan-20-one (Supplementary Concept)
  • 20-oxo-5-pregnan-3-yl-glutamyl 1-ester (Supplementary Concept)
  • tetrahydrodeoxycorticosterone (Supplementary Concept)
  • histidyl-proline diketopiperazine (Supplementary Concept)
  • sipatrigine (Supplementary Concept)
  • pyrrolidine-2,4-dicarboxylic acid (Supplementary Concept)
  • nefazodone (Supplementary Concept)
  • ammuxetine (Supplementary Concept)
  • femoxetine (Supplementary Concept)
  • indalpine (Supplementary Concept)
  • alaproclate (Supplementary Concept)
  • dual orexin receptor antagonist 12 (Supplementary Concept)
  • lemborexant (Supplementary Concept)
  • suvorexant (Supplementary Concept)
  • DORA-22 (Supplementary Concept)
  • 2-methylthio-ATP (Supplementary Concept)
  • 2-hexyloxyadenosine (Supplementary Concept)
  • 2-(2-phenylethoxy)adenosine (Supplementary Concept)
  • binodenoson (Supplementary Concept)
  • 2-chloro-N(6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide (Supplementary Concept)
  • N6-(4-(((4-((((2-((((isothiocyanatophenyl)amino)thiocarbonyl)amino)ethyl)amino)carbonyl)methyl)anilino)carbonyl)methyl)phenyl)adenosine (Supplementary Concept)
  • N(6)-(4-sulfophenyl)adenosine (Supplementary Concept)
  • 2-(3-hydroxy-3-phenyl-1-propyn-1-yl)-5'-N-ethylcarboxamidoadenosine (Supplementary Concept)
  • 2-((phenylisopropyl)amino)adenosine (Supplementary Concept)
  • 2-((1-phenylpropyl)amino)adenosine (Supplementary Concept)
  • N(6)-benzyl-5'-N-ethylcarboxamidoadenosine (Supplementary Concept)
  • N(6)-cyclopentyl-2-(3-phenylaminocarbonyltriazene-1-yl)adenosine (Supplementary Concept)
  • N(6)-cyclopentyladenosine (Supplementary Concept)
  • N-((1S,trans)-2-hydroxycyclopentyl)adenosine (Supplementary Concept)
  • ethyl 2-amino-3-benzoyl-4,7-dihydrothieno(2,3-c)pyridine-6(5H)-carboxylate (Supplementary Concept)
  • RS 74513-000 (Supplementary Concept)
  • CVT 2759 (Supplementary Concept)
  • N-(3-iodobenzyl)-5'-O-methyladenosine (Supplementary Concept)
  • 5'-O-ethyl-N-(3-iodobenzyl)adenosine (Supplementary Concept)
  • VUF 5455 (Supplementary Concept)
  • KMCP 98 (Supplementary Concept)
  • 8-butylaminoadenosine (Supplementary Concept)
  • 8-butylamino-N(6)-cyclopentyladenosine (Supplementary Concept)
  • tecadenoson (Supplementary Concept)
  • 8-methylamino-N6-cyclopentyladenosine (Supplementary Concept)
  • 2'-deoxyribose-N6-cyclopentyladenosine (Supplementary Concept)
  • 2-amino-4-benzo(1,3)dioxol-5-yl-6-(2-hydroxyethylsulfanyl)pyridine-3,5-dicarbonitrile (Supplementary Concept)
  • 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine (Supplementary Concept)
  • aminopyridine-3,5-dicarbonitrile (Supplementary Concept)
  • regadenoson (Supplementary Concept)
  • PSB-0777 (Supplementary Concept)
  • BAY 60-6583 (Supplementary Concept)
  • 2-(3''-(6''-bromoindolyl)ethyloxy)adenosine (Supplementary Concept)
  • GW 328267 (Supplementary Concept)
  • 2-amino-4-(4-hydroxyphenyl)-6-(1H-imidazol-2-ylmethylsulfanyl)pyridine-3,5-dicarbonitrile (Supplementary Concept)
  • 2-chloro-N(6)-methyladenosine-5'-methyluronamide (Supplementary Concept)
  • 2-chloro-N(6)-(3-iodobenzyl)-5'-N-methylcarbamoyl-4'-thioadenosine (Supplementary Concept)
  • ABEA-X-BY630 (Supplementary Concept)
  • CF 502 (Supplementary Concept)
  • N6-methoxy-2-(4-acetylphenyl)ethynyl-5'-N-methylcarboxamidoadenosine (Supplementary Concept)
  • 4'-(2-chloro-6-(3-iodobenzylamino)purine)-2',3'-O-dihydroxy-bicyclo(3.1.0)hexane (Supplementary Concept)
  • MRS 2219 (Supplementary Concept)
  • iso-iantheran A (Supplementary Concept)
  • iso-iantheran B (Supplementary Concept)
  • 8-carboxy-iso-iantheran A (Supplementary Concept)
  • 3-phenacyluridine diphosphate (Supplementary Concept)
  • 2'-amino-2'-deoxy-2-thiouridine 5'-triphosphate (Supplementary Concept)
  • INS 48823 (Supplementary Concept)
  • NF 279 (Supplementary Concept)
  • MRS 1097 (Supplementary Concept)
  • alpha-((4-amino-1-phenylpyrazolo(3,4-d)pyrimidin-6-yl)thio)hexanamide (Supplementary Concept)
  • alpha-((4-(methylamino)-1-phenylpyrazolo(3,4-d)pyrimidin-6-yl)thio)hexanamide (Supplementary Concept)
  • KF 20274 (Supplementary Concept)
  • 3,6-dichloro-2'-isopropyloxy-4'-methylflavone (Supplementary Concept)
  • 1,3-dipropyl-8-(4-sulfophenyl)xanthine (Supplementary Concept)
  • 8-cyclopentyl-1,3-dimethylxanthine (Supplementary Concept)
  • 2,4-diethyl-1-methyl-3-(ethylsulfanylcarbonyl)-5-ethyloxycarbonyl-6-phenylpyridinium (Supplementary Concept)
  • MRE 3008-F20 (Supplementary Concept)
  • MRS 1204 (Supplementary Concept)
  • MRS 1595 (Supplementary Concept)
  • 8-(4-sulfophenyl)theophylline (Supplementary Concept)
  • (2-amino-4,5,6,7-tetrahydrobenzo(b)thiophen-3-yl)(4-chloronaphthalen-1-yl)methanone (Supplementary Concept)
  • (2-amino-4,5,6,7-tetrahydrobenzo(b)thiophen-3-yl)(4-iodonaphthalen-1-yl)methanone (Supplementary Concept)
  • KFM 19 (Supplementary Concept)
  • WRC 0571 (Supplementary Concept)
  • MRS 1740 (Supplementary Concept)
  • MRS 1741 (Supplementary Concept)
  • 2,3-diethyl-4,5-dipropyl-6-phenylpyridine-3-thiocarboxylate-5-carboxylate (Supplementary Concept)
  • 8-cyclopentyl-3-(3-(4-fluorosulfonylbenzamido)propyl)-1-propylxanthine (Supplementary Concept)
  • VUF 5472 (Supplementary Concept)
  • 5-(((4-fluorosulfonylphenyl)amino)carbonyl)amino-8-n-propyl-2-(2-furyl)pyrazolol(4,3-e)1,2,4-triazolo(1,5-c)pyrimidine (Supplementary Concept)
  • 1-benzyl-3-propyl-1H,3H-pyrido(2,1-f)purine-2,4-dione (Supplementary Concept)
  • 5-(((4-pyridyl)amino)carbonyl)amino-8-methyl-2-(2-furyl)pyrazolo(4,3-e)1,2,4-triazolo(1,5-c)pyrimdiine (Supplementary Concept)
  • 1-((7-methyl-2-phenylimidazo(1,2-a)(1,3,5)triazin-4-yl)amino)acetone (Supplementary Concept)
  • 8-cyclopenta-3-(3-fluoropropyl)-1-propylxanthine (Supplementary Concept)
  • KF 17387 (Supplementary Concept)
  • 8-cyclohexylcaffeine (Supplementary Concept)
  • 8-dipropyl-8-cyclopentylxanthine (Supplementary Concept)
  • FSPTP pyrimidine (Supplementary Concept)
  • N-(3-(2-pyridinyl)isoquinolin-1-yl)benzamidine (Supplementary Concept)
  • VUF 8504 (Supplementary Concept)
  • propyl 1-ethyl-8-oxo-3-phenyl-5,6,7,8-tetrahydro-7-thiaisoquinoline-4-carboxylate (Supplementary Concept)
  • 4-amino-6-benzylamino-1,2-dihydro-2-phenyl-1,2,4-triazolo(4,3-a)-quinoxalin-1-one (Supplementary Concept)
  • 3-(2-(4-aminophenyl)ethyl)-8-benzyl-7-(2-ethyl(2-hydroxyethyl)aminoethyl)-1-propyl-3,7-dihydropurine-2,6-dione (Supplementary Concept)
  • methyl 1-(2-chloro-2-phenylethyl)-4-((2-(4-methoxyphenyl)ethyl)amino)-1H-pyrazolo(3,4-b)pyridine-5-carboxylate (Supplementary Concept)
  • isopropyl 1-(2-chloro-2-phenylethyl)-4-((2-(4-methoxyphenyl)ethyl)amino)-1H-pyrazolo(3,4-b)pyridine-5-carboxylate (Supplementary Concept)
  • 8-cyclopentyl-2,6-diphenylpurine (Supplementary Concept)
  • 5-(5-amino-3-(4-fluorophenyl)pyrazin-2-yl)-1-isopropylprydine-2(1H)-one (Supplementary Concept)
  • 5-N-methylimino-2-(3-methylphenyl)-3-phenyl-2H-(1,2,4)-thiadiazole (Supplementary Concept)
  • 1-propyl-8-(4-((4-nitrophenoxy)sulfonyl)phenyl)xanthine (Supplementary Concept)
  • 1-butyl-8-(4-((4-nitrophenoxy)sulfonyl)phenyl)xanthine (Supplementary Concept)
  • 1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine (Supplementary Concept)
  • 1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine (Supplementary Concept)
  • 1,3-dipropyl-8-cyclopentylxanthine (Supplementary Concept)
  • 1-butyl-3-(3-hydroxypropyl)-8-(3-noradamantyl)xanthine (Supplementary Concept)
  • 9-butyl-2-(3-noradamantyl)-4,5-dihydro-6H,8H-pyrimido(1,2,3-cd)purine-8,10-dione (Supplementary Concept)
  • 7,8-dihydro-8-ethyl-2-(4-bicyclo(2.2.2)octan-1-ol)-4-propyl-1H-imidazo(2,1-i)purin-5(4H)-one (Supplementary Concept)
  • 7-chloro-4-hydroxy-2-phenyl-1,8-naphthyridine (Supplementary Concept)
  • 3,4',5-tri(glucose-3-O-succinyl)resveratrol (Supplementary Concept)
  • 8-cyclopentyl-3-(3-iodoprop-2-en-1-yl)-1-propylxanthine (Supplementary Concept)
  • N-(4,6-diphenylpyrimidin-2-yl)butyramide (Supplementary Concept)
  • 2-(1-methyl-4-piperidinyl)-6-(2-phenylpyrazolo(1,5-a)pyridin-3-yl)-3(2H)-pyridazinone (Supplementary Concept)
  • 2-amino-4-(3-trifluoromethylphenyl)-6-(2-hydroxyethylsulfanyl)pyridine-3,5-dicarbonitrile (Supplementary Concept)
  • enprofylline (Supplementary Concept)
  • istradefylline (Supplementary Concept)
  • 3-(3-hydroxypropyl)-8-(3-methoxystyryl)-7-methyl-1-propargylxanthine (Supplementary Concept)
  • 2-n-butyl-9-methyl-8-(1,2,3)triazol-2-yl-9H-purin-6-ylamine (Supplementary Concept)
  • 6-methyl-7-(1,2,3)triazol-2-yl-1,6-dihydrobenzo(1,2-d-3,4-d')diimidazole (Supplementary Concept)
  • 5-oxazol-2-yl-1H-pyrazolo(4,3-b)pyridin-3-ylamine (Supplementary Concept)
  • 5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine (Supplementary Concept)
  • 8-(1-(3-(trifluoromethyl)benzyl)-1H-pyrazol-4-yl)-1,3-dimethylxanthine (Supplementary Concept)
  • SCH 442416 (Supplementary Concept)
  • 3,7-dimethyl-1-propargylxanthine (Supplementary Concept)
  • (7-(2-(4-difluorophenyl)-1-piperazinyl)ethyl)-2-(2-furanyl)-7H-pyrazolo(4,3-e)(1,2,4)triazolo(1,5-c)pyrimidin-5-amine (Supplementary Concept)
  • 8-(4-(4-benzylpiperazide-1-sulfonyl)phenyl)-1-propylxanthine (Supplementary Concept)
  • 1-propyl-8-(4-sulfophenyl)xanthine (Supplementary Concept)
  • 4'-(2-furyl)-N-pyridin-3-yl-4,5'-bipyrimidin-2'-amine (Supplementary Concept)
  • 3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine (Supplementary Concept)
  • N-(2-(2-phenyl-6-(4-(3-phenylpropyl)piperazine-1-carbonyl)-7H-pyrrolo(2,3-d)pyrimidin-4-ylamino)ethyl)acetamide (Supplementary Concept)
  • N-(4-acetylphenyl)-2-(4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy)acetamide (Supplementary Concept)
  • 9-chloro-2-(2-furyl)-5-phenylacetylamino(1,2,4)triazolo(1,5-c)quinazoline (Supplementary Concept)
  • 1-benzyl-7-methyl-3-propyl-1H,8H-imidazo(2,1-f)purine-2,4-dione (Supplementary Concept)
  • 2-(4-methoxyphenyl)-1,2,4-triazolo(1,5-a)quinoxalin-4-one (Supplementary Concept)
  • 4-diphenylacetylamino-2-phenylpyrazoloquinoline (Supplementary Concept)
  • 4-dibenzoylamino-2-(4-methoxyphenyl)pyrazoloquinoline (Supplementary Concept)
  • 9-chloro-5-(4-methoxybenzoyl)amino-2-phenyl(1,2,3)triazolo(1,2-a)(1,2,4)benzotriazin-1-one (Supplementary Concept)
  • 4-benzoylamino-2-(4-methoxyphenyl)pyrido(2,3-e)-1,2,4-triazolo(4,3-a)pyrazin-1-one (Supplementary Concept)
  • SB 204070A (Supplementary Concept)
  • N-(2-(phenyl)-8-methylpyrazolo(4,3-e)(1,2,4)triazolo(1,5-c)pyrimidin-5-yl)phenylacetamide (Supplementary Concept)
  • 2-(4-nitrophenyl)-1,2,4,5-tetrahydro-1,2,4-triazolo(4,3-a)quinoxaline-1,4-dione (Supplementary Concept)
  • LJ-2698 (Supplementary Concept)
  • MRS 2220 (Supplementary Concept)
  • AR C109318XX (Supplementary Concept)
  • 8,8',8'',8'''-(carbonylbis(imino-5,13-benzenetriyl-bis(carbonylimino)))tetrakisnaphthalene-1,3,5-trisulfonic acid (Supplementary Concept)
  • 2-(2-(6-methylaminopurin-9-yl)ethyl)propane-1,3-bisoxy(diammonium phosphate) (Supplementary Concept)
  • pyridoxal-5'-phosphate-6-(2'-naphthylazo-6'-nitro-4',8'-disulfonate) (Supplementary Concept)
  • INS 50589 (Supplementary Concept)
  • (6-(6-(3-ethylureido)-9H-purin-9-yl)-2-styryltetrahydrofuro(3,4-d)(1,3)dioxol-4-yl)methyl dihydrogen phosphate (Supplementary Concept)
  • 4-((4-(1-(ethoxycarbonyl)-1-methylethoxy)-7-methyl-2-quinolyl)carbamoyl)-5-(4-(ethoxycarbonyl)piperazin-1-yl)-5-oxopentanoic acid (Supplementary Concept)
  • N-(adamantan-1-ylmethyl)-5-((3-aminopyrrolidin-1-yl)methyl)-2-chlorobenzamide (Supplementary Concept)
  • 1-(N,O-bis(isoquinolinesulfonyl)-N-methyltyrosyl)-4-(4-fluorophenyl)piperazine (Supplementary Concept)
  • 4-(2-iodo-6-methylaminopurin-9-yl)-1-((phosphato)methyl)-2-(phosphato)bicyclo(3.1.0)hexane (Supplementary Concept)
  • uridine-5'-O-(3-thiotriphosphate) (Supplementary Concept)
  • 2,2'-pyridylisatogen tosylate (Supplementary Concept)
  • NP-1815-PX (Supplementary Concept)
  • JNJ-55308942 (Supplementary Concept)
  • AZ 11645373 (Supplementary Concept)
  • N(6)-methyl-2'-deoxyadenosine 3',5'-diphosphate (Supplementary Concept)
  • ARC 118925XX (Supplementary Concept)
  • clopidogrel carboxylic acid (Supplementary Concept)
  • cangrelor (Supplementary Concept)
  • FG 5893 (Supplementary Concept)
  • RP5063 (Supplementary Concept)
  • 4-iodo-2,5-dimethoxyphenylisopropylamine (Supplementary Concept)
  • 1-(3-trifluoromethylphenyl)piperazine (Supplementary Concept)
  • binospirone mesylate (Supplementary Concept)
  • eltoprazine (Supplementary Concept)
  • 2,5-dimethoxy-4-bromoamphetamine (Supplementary Concept)
  • 3-(1,2,5,6-tetrahydropyrid-4-yl)pyrrolo(3,2-b)pyrid-5-one (Supplementary Concept)
  • 5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1H indole (Supplementary Concept)
  • frovatriptan (Supplementary Concept)
  • 4-fluoro-N-(3-(1-methyl-4-piperidinyl)-1H-indol-5-yl)benzamide (Supplementary Concept)
  • LY 302148 (Supplementary Concept)
  • LY 306258 (Supplementary Concept)
  • CP 2289 (Supplementary Concept)
  • 6-(4-methyl-1-piperazinyl)-7,8,9,10-tetrahydrophenanthridine (Supplementary Concept)
  • 6-(4-methyl-1-piperazinyl)--7,8,9,10-tetrahydro-8,10-ethanophenanthridine (Supplementary Concept)
  • CGS 12066B (Supplementary Concept)
  • indorenate (Supplementary Concept)
  • gepirone (Supplementary Concept)
  • alpha-methylserotonin (Supplementary Concept)
  • L 772405 (Supplementary Concept)
  • almotriptan (Supplementary Concept)
  • tandospirone (Supplementary Concept)
  • flesinoxan (Supplementary Concept)
  • ipsapirone (Supplementary Concept)
  • LY 165163 (Supplementary Concept)
  • lasmiditan (Supplementary Concept)
  • mosapride (Supplementary Concept)
  • 6-chloro-2-(1-piperazinyl)pyrazine (Supplementary Concept)
  • 1-(3-chlorophenyl)piperazine (Supplementary Concept)
  • rizatriptan (Supplementary Concept)
  • phenyl biguanide (Supplementary Concept)
  • 5-carboxamidotryptamine (Supplementary Concept)
  • N-(3-(2-dimethylaminoethyl)-2-methyl-1H-indol-5-yl)-4-fluorobenzamide (Supplementary Concept)
  • 3,4-dihydro-N-isopropyl-3-(N-isopropyl-N-propylamino)-2H-1-benzopyran-5-carboxamide (Supplementary Concept)
  • 4-(4-(3-methoxyphenyl)cyclohexyl)-1-(2-pyridinyl)piperazine (Supplementary Concept)
  • N-(4-(3-methoxyphenyl)cyclohexyl)-2-(2-pyridyloxy)ethylamine (Supplementary Concept)
  • tegaserod (Supplementary Concept)
  • SDZ 219-964 (Supplementary Concept)
  • RS 67532 (Supplementary Concept)
  • 4-(2-methylthiophenyl)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1-piperazinehexanamide (Supplementary Concept)
  • dimethoxy-4-indophenyl-2-aminopropane (Supplementary Concept)
  • eletriptan (Supplementary Concept)
  • (3,4-dichlorophenyl)(4-((6-oxazol-5-ylpyridin-2-ylmethylamino)methyl)piperidin-1-yl)methanone (Supplementary Concept)
  • (3,4-dichlorophenyl)(4-((6-azetidinopyridin-2-ylmethylamino)methyl)piperidin-1-yl)methanone (Supplementary Concept)
  • 3-(3-(N-benzylaminomethyl)pyrrolidinyl)-5-((2-oxooxazolidin-4-yl)methyl)indole (Supplementary Concept)
  • 3-(3-(N-(alpha-methylbenzyl)aminomethyl)pyrrolidiny)-5-((2-oxooxazolidinyl)methyl)indole (Supplementary Concept)
  • 1-(3-(5-(1,2,4-triazol-4-yl)-1H-indol-3-yl)propyl)-4-(2-(3-fluorophenyl)ethyl)piperazine (Supplementary Concept)
  • N-methyl-5-tert-butyltryptamine (Supplementary Concept)
  • 1-(3-chlorophenyl)biguanide (Supplementary Concept)
  • zolmitriptan (Supplementary Concept)
  • repinotan hydrochloride (Supplementary Concept)
  • cyclohexanecarboxylic acid (2-(4-(2-bromo-5-methoxybenzyl)piperazin-1-yl)ethyl)-(2-trifluoromethoxyphenyl)amide (Supplementary Concept)
  • cyclohexanecarboxylic acid, (2-methoxyphenyl)-(2-(4-(2-methoxyphenyl)piperazin-1-yl)ethyl)amide (Supplementary Concept)
  • 2-(4-(4-(7-methoxynaphthalen-1-yl)piperazin-1-yl)butyl)-4-methyl-2H-(1,2,4)triazine-3,5-dione (Supplementary Concept)
  • Piclozotan (Supplementary Concept)
  • 3-chloro-4-fluorophenyl-(4-fluoro-4-(((5-methylpyrimidin-2-ylmethyl)amino)methyl)piperidin-1-yl)methanone (Supplementary Concept)
  • 2-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5-(2H,4H)-dione (Supplementary Concept)
  • 3-amino-5,6,7,8-tetrahydro-2-(4-(4-(quinolin-2-yl)piperazin-1-yl)butyl)quinazolin-4-(3H)-one (Supplementary Concept)
  • befiradol (Supplementary Concept)
  • 2-((4-(naphth-1-yl)piperazin-1-yl)methyl)-1,4-dioxoperhydropyrrolo(1,2-a)pyrazine (Supplementary Concept)
  • 8-((3-(4-(2-methoxyphenyl)piperazin-1-yl)-2-hydroxypropyl)oxy)thiochroman (Supplementary Concept)
  • naluzotan (Supplementary Concept)
  • xaliproden (Supplementary Concept)
  • 6-methyl-2-(4-(naphthylpiperazin-1-yl)butyl)-3-(2H)-pyridazinone (Supplementary Concept)
  • naratriptan (Supplementary Concept)
  • PNU 142093 (Supplementary Concept)
  • N-methyl-2'-methyl-2',3'-dihydrofuro(m)aporphine (Supplementary Concept)
  • 11-propargyloxy-N-methylaporphine (Supplementary Concept)
  • 11-allyloxy-N-methylaporphine (Supplementary Concept)
  • 1-(2-aminopropyl)-1H-indazol-6-ol (Supplementary Concept)
  • 1-(3-(2-((2-ethoxy-3-pyridinyl)oxy)ethoxy)-2-pyrazinyl)-2-methylpiperazine (Supplementary Concept)
  • N,N-dimethyllysergamide (Supplementary Concept)
  • 4-acetoxy-dimethyltryptamine (Supplementary Concept)
  • AR231630 (Supplementary Concept)
  • 2-(8,9-dihydro-7H-pyrano(2,3-g)indazol-1-yl)-1-methylethylamine (Supplementary Concept)
  • (2-(3-methylphenyl)cyclopropyl)methylamine (Supplementary Concept)
  • C-(4,5,6-trimethoxyindan-1-yl)methanamine (Supplementary Concept)
  • 9-ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino(2,1-a)isoindol-6(2H)-one (Supplementary Concept)
  • 1-(2-aminopropyl)-1H-indazole-6-ol (Supplementary Concept)
  • 1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta(b)(1,4)diazepino(6,7,1hj)indole (Supplementary Concept)
  • 5-chloro-7-methyl-2-(1-homopiperazinyl)benzoxazole (Supplementary Concept)
  • 1-oxo-5-hydroxytryptamine (Supplementary Concept)
  • prucalopride (Supplementary Concept)
  • 6,7-dihydro-4-hydroxy-7-isopropyl-6-oxo-N-(3-(piperidin-1-yl)propyl)thieno(2,3-b)pyridine-5-carboxamide (Supplementary Concept)
  • CJ 033466 (Supplementary Concept)
  • minesapride (Supplementary Concept)
  • ATI 7505 (Supplementary Concept)
  • YH12852 (Supplementary Concept)
  • MP3950 (Supplementary Concept)
  • 1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate (Supplementary Concept)
  • clovoxamine (Supplementary Concept)
  • azasetron (Supplementary Concept)
  • ramosetron (Supplementary Concept)
  • altanserin (Supplementary Concept)
  • 2-methoxy-4-amino-5-chlorobenzoic acid 2-(diethylamino)ethyl ester (Supplementary Concept)
  • UH 301 (Supplementary Concept)
  • sarpogrelate (Supplementary Concept)
  • zatosetron (Supplementary Concept)
  • 4-(2'-methoxyphenyl)-1-(2'-(N-(2''-pyridinyl)-4-iodobenzamido)ethyl)piperazine (Supplementary Concept)
  • N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide (Supplementary Concept)
  • GR 127935 (Supplementary Concept)
  • alosetron (Supplementary Concept)
  • SR 46349B (Supplementary Concept)
  • DuP 734 (Supplementary Concept)
  • volinanserin (Supplementary Concept)
  • 3,N-dimethyl-N-(1-methyl-3-(4-methylpiperidin-1-yl)propyl)benzenesulfonamide (Supplementary Concept)
  • xylamidine (Supplementary Concept)
  • renzapride (Supplementary Concept)
  • LY 53857 (Supplementary Concept)
  • bemesetron (Supplementary Concept)
  • 2-amino-4-(4-fluoronaphth-1-yl)-6-isopropylpyrimidine (Supplementary Concept)
  • 1-(2-methoxyphenyl)-4-(4--(2-phthalimido)cyclohexyl)piperazine (Supplementary Concept)
  • 4-(3-(1-benzotriazolyl)cyclohexyl)-1-(2-methoxyphenyl)piperazine (Supplementary Concept)
  • N-(1-azabicyclo(2.2.2)oct-3-yl)benzimidazole-4-carboxamide (Supplementary Concept)
  • N-(1-azabicyclo(2.2.2)oct-3-yl)--6-chlorobenzimidazole-4-carboxamide (Supplementary Concept)
  • N-(1-azabicyclo(2.2.2)oct-3-yl)-6--chloro-7-nitrobenzimidazole-4-carboxamide (Supplementary Concept)
  • 2-ethyl-5-methoxy-N,N-dimethyltryptamine (Supplementary Concept)
  • LY 426965 (Supplementary Concept)
  • SL 88.0338 (Supplementary Concept)
  • 6-nitroquipazine (Supplementary Concept)
  • 5-((N-propylpiperidin-4-yl)methoxy)-1,2,3,4-tetrahydrobenzo(h)(1,6)naphthyridine (Supplementary Concept)
  • N-(5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl)-4-morpholinobenzamide (Supplementary Concept)
  • 2-(4-((6-amino-1,3-dioxo-1H-benzo(de)isoquinolin-2(3H)-yl)methyl)piperidin-1-yl)ethyl 4-amino-5-chloro-2-methoxybenzoate (Supplementary Concept)
  • 3-(benzenesulfonyl)-2-(methylsulfanyl)pyrido(1,2-a)pyrimidin-4-ylidenamine (Supplementary Concept)
  • cianopramine (Supplementary Concept)
  • zacopride (Supplementary Concept)
  • pipamperone (Supplementary Concept)
  • setoperone (Supplementary Concept)
  • (2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine (Supplementary Concept)
  • deramciclane (Supplementary Concept)
  • AVN-492 (Supplementary Concept)
  • WAY 100135 (Supplementary Concept)
  • GR 113808 (Supplementary Concept)
  • dotarizine (Supplementary Concept)
  • SB 206553 (Supplementary Concept)
  • LY 367265 (Supplementary Concept)
  • REC 15-3079 (Supplementary Concept)
  • 4-((1-(2-(2,4-difluorophenyl)ethyl)-4-piperidinyl)sulfonyl)benzonitrile (Supplementary Concept)
  • 4-((1-(2-(2,4-difluorophenyl)ethyl)-4-piperidinyl)sulfonyl)benzamide (Supplementary Concept)
  • 1-(4-fluorophenyl)-2-(4-(phenylsulfonyl)-1-piperidinyl)ethanone (Supplementary Concept)
  • LY 393558 (Supplementary Concept)
  • 2-((2-(dimethylamino)ethyl)thio)-3-phenylquinoline (Supplementary Concept)
  • McN 5652 (Supplementary Concept)
  • 1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine (Supplementary Concept)
  • tolfenamic acid (Supplementary Concept)
  • iprazochrome (Supplementary Concept)
  • amperozide (Supplementary Concept)
  • butanserin (Supplementary Concept)
  • 3-(3-(dimethylamino)propyl)-4-hydroxy-N-(4-(4-pyridinyl)phenyl)benzamide (Supplementary Concept)
  • 8-(5-(5-amino-2,4-dimethoxyphenyl)-5-oxopentyl)-1,3,8-triazaspiro(4.5)decane-2,4-dione (Supplementary Concept)
  • 2a-(4-phenyl-1,2,3,6-tetrahydropyridyl)cyclohex(a-3,4)indole-2-one (Supplementary Concept)
  • 2-(3,5-dimethylpiperidino)ethyl 4-amino-5-chloro-2-methoxybenzoate (Supplementary Concept)
  • 5-(4-fluorophenyl)-3-(2-hydroxy-3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)-5-methylhydantoin (Supplementary Concept)
  • BRL 15572 (Supplementary Concept)
  • MM 77 (Supplementary Concept)
  • N-(8'-hydroxy-2'-methyl-5'-(2-methylpropyl)-3',6'-dioxo-7'-(phenylmethyl)oxazolidino(2,3-c)piperazin-2'-yl) 6-methylergoline-8-carboxamide (Supplementary Concept)
  • 5-fluoro-8-(4-(4-(6-methoxyquinolin-8-yl)piperazin-1-yl)piperidin-1-yl)quinoline (Supplementary Concept)
  • isamoltane (Supplementary Concept)
  • 3-(cyclobutyl(3-(5-fluoro-1H-indol-3-yl)propyl)amino)-8-fluorochromane-5-carboxamide (Supplementary Concept)
  • 1-(4-(2-methoxyisopropyl)phenyl)-3-(2-(4-methylpiperazin-1-yl)benzyl)pyrrolidin-2-one (Supplementary Concept)
  • pimavanserin (Supplementary Concept)
  • AR 246686 (Supplementary Concept)
  • APD791 (Supplementary Concept)
  • 5-(((4-benzo(a)isothiazol-3-yl)piperazin-1-yl)methyl)-6-chloroindolin-2-one (Supplementary Concept)
  • 2-(4-methoxyphenyl)-N-(4-methylbenzyl)-N-(1-methylpiperidin-4-yl)acetamide (Supplementary Concept)
  • itasetron (Supplementary Concept)
  • dolasetron (Supplementary Concept)
  • 3-(4-methoxybenzyl)-N-(3-(2-piperidin-1-yl)ethyl)-2,4-dioxoquinazoline-7-carboxamide (Supplementary Concept)
  • 2-(4-allylpiperazin-1-yl)-1,8-naphthyridine-3-carbonitrile (Supplementary Concept)
  • hexahydro-1H-pyrrolizin-1-ylmethyl 1-methyl-1H-indole-3-carboxylate (Supplementary Concept)
  • Prenylamine (MeSH Term)
  • Debrisoquin (MeSH Term)
  • Benzphetamine (MeSH Term)
  • Bethanidine (MeSH Term)
  • Guanethidine (MeSH Term)
  • Amphetamine (MeSH Term)
  • Ephedrine (MeSH Term)
  • Methamphetamine (MeSH Term)
  • Phentermine (MeSH Term)
  • Oxidopamine (MeSH Term)
  • Naphazoline (MeSH Term)
  • Norepinephrine (MeSH Term)
  • Octopamine (MeSH Term)
  • Oxymetazoline (MeSH Term)
  • Synephrine (MeSH Term)
  • Epinephrine (MeSH Term)
  • Etilefrine (MeSH Term)
  • Racepinephrine (MeSH Term)
  • Phenylpropanolamine (MeSH Term)
  • Mephentermine (MeSH Term)
  • Midodrine (MeSH Term)
  • Ergotamine (MeSH Term)
  • Metaraminol (MeSH Term)
  • Methoxamine (MeSH Term)
  • Phenylephrine (MeSH Term)
  • Guanfacine (MeSH Term)
  • Brimonidine Tartrate (MeSH Term)
  • Brimonidine Tartrate, Timolol Maleate Drug Combination (MeSH Term)
  • Clonidine (MeSH Term)
  • Guanabenz (MeSH Term)
  • Methyldopa (MeSH Term)
  • Xylazine (MeSH Term)
  • Medetomidine (MeSH Term)
  • Dexmedetomidine (MeSH Term)
  • Rilmenidine (MeSH Term)
  • Tretoquinol (MeSH Term)
  • Isoproterenol (MeSH Term)
  • Isoxsuprine (MeSH Term)
  • Nylidrin (MeSH Term)
  • Oxyfedrine (MeSH Term)
  • Clenbuterol (MeSH Term)
  • Nebivolol (MeSH Term)
  • Prenalterol (MeSH Term)
  • Xamoterol (MeSH Term)
  • Dobutamine (MeSH Term)
  • Terbutaline (MeSH Term)
  • Salmeterol Xinafoate (MeSH Term)
  • Formoterol Fumarate (MeSH Term)
  • Isoetharine (MeSH Term)
  • Metaproterenol (MeSH Term)
  • Procaterol (MeSH Term)
  • Fenoterol (MeSH Term)
  • Albuterol (MeSH Term)
  • Ritodrine (MeSH Term)
  • Hexoprenaline (MeSH Term)
  • Bretylium Tosylate (MeSH Term)
  • Dihydroergocristine (MeSH Term)
  • Moxisylyte (MeSH Term)
  • Tolazoline (MeSH Term)
  • Dibenzylchlorethamine (MeSH Term)
  • Dihydroergotoxine (MeSH Term)
  • Nicergoline (MeSH Term)
  • Mianserin (MeSH Term)
  • Quinidine (MeSH Term)
  • Ergoloid Mesylates (MeSH Term)
  • Phenoxybenzamine (MeSH Term)
  • Phentolamine (MeSH Term)
  • Piperoxan (MeSH Term)
  • Labetalol (MeSH Term)
  • Prazosin (MeSH Term)
  • Doxazosin (MeSH Term)
  • Carvedilol (MeSH Term)
  • Indoramin (MeSH Term)
  • Tamsulosin (MeSH Term)
  • Lurasidone Hydrochloride (MeSH Term)
  • Idazoxan (MeSH Term)
  • Yohimbine (MeSH Term)
  • Mirtazapine (MeSH Term)
  • Levobunolol (MeSH Term)
  • Bupranolol (MeSH Term)
  • Penbutolol (MeSH Term)
  • Timolol (MeSH Term)
  • Propranolol (MeSH Term)
  • Dihydroalprenolol (MeSH Term)
  • Nadolol (MeSH Term)
  • Oxprenolol (MeSH Term)
  • Iodocyanopindolol (MeSH Term)
  • Alprenolol (MeSH Term)
  • Carteolol (MeSH Term)
  • Sotalol (MeSH Term)
  • Metipranolol (MeSH Term)
  • Bunolol (MeSH Term)
  • Pindolol (MeSH Term)
  • Betaxolol (MeSH Term)
  • Acebutolol (MeSH Term)
  • Practolol (MeSH Term)
  • Celiprolol (MeSH Term)
  • Bisoprolol (MeSH Term)
  • Atenolol (MeSH Term)
  • Metoprolol (MeSH Term)
  • Butoxamine (MeSH Term)
  • Tetrabenazine (MeSH Term)
  • Atomoxetine Hydrochloride (MeSH Term)
  • Maprotiline (MeSH Term)
  • Mazindol (MeSH Term)
  • Protriptyline (MeSH Term)
  • Desipramine (MeSH Term)
  • Nortriptyline (MeSH Term)
  • Opipramol (MeSH Term)
  • N-Methyl-3,4-methylenedioxyamphetamine (MeSH Term)
  • Amitriptyline (MeSH Term)
  • Amoxapine (MeSH Term)
  • Reserpine (MeSH Term)
  • Dothiepin (MeSH Term)
  • Imipramine (MeSH Term)
  • Trimipramine (MeSH Term)
  • Tyramine (MeSH Term)
  • Viloxazine (MeSH Term)
  • 3,4-Methylenedioxyamphetamine (MeSH Term)
  • Tapentadol (MeSH Term)
  • Reboxetine (MeSH Term)
  • Dronabinol (MeSH Term)
  • Rimonabant (MeSH Term)
  • Hemicholinium 3 (MeSH Term)
  • Holothurin (MeSH Term)
  • Botulinum Toxins (MeSH Term)
  • Botulinum Toxins, Type A (MeSH Term)
  • Arecoline (MeSH Term)
  • Carbachol (MeSH Term)
  • Acetylcholine (MeSH Term)
  • Methacholine Chloride (MeSH Term)
  • (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride (MeSH Term)
  • Muscarine (MeSH Term)
  • Oxotremorine (MeSH Term)
  • Bethanechol (MeSH Term)
  • Pilocarpine (MeSH Term)
  • Varenicline (MeSH Term)
  • Lobeline (MeSH Term)
  • Nicotine (MeSH Term)
  • Dimethylphenylpiperazinium Iodide (MeSH Term)
  • Tiotropium Bromide (MeSH Term)
  • Meclizine (MeSH Term)
  • Ipratropium (MeSH Term)
  • Scopolamine (MeSH Term)
  • Butylscopolammonium Bromide (MeSH Term)
  • Tolterodine Tartrate (MeSH Term)
  • Solifenacin Succinate (MeSH Term)
  • Procyclidine (MeSH Term)
  • Propantheline (MeSH Term)
  • Propylbenzilylcholine Mustard (MeSH Term)
  • Dexetimide (MeSH Term)
  • Dicyclomine (MeSH Term)
  • Orphenadrine (MeSH Term)
  • Oxyphenonium (MeSH Term)
  • Benactyzine (MeSH Term)
  • Benztropine (MeSH Term)
  • Biperiden (MeSH Term)
  • Cyclopentolate (MeSH Term)
  • Glycopyrrolate (MeSH Term)
  • Atropine (MeSH Term)
  • Quinuclidinyl Benzilate (MeSH Term)
  • Emepronium (MeSH Term)
  • Trihexyphenidyl (MeSH Term)
  • Tropicamide (MeSH Term)
  • Hyoscyamine (MeSH Term)
  • Pirenzepine (MeSH Term)
  • Methantheline (MeSH Term)
  • Pancuronium (MeSH Term)
  • Pempidine (MeSH Term)
  • Pentolinium Tartrate (MeSH Term)
  • Toxiferine (MeSH Term)
  • Mecamylamine (MeSH Term)
  • Pipecuronium (MeSH Term)
  • Hexamethonium (MeSH Term)
  • Curare (MeSH Term)
  • Gallamine Triethiodide (MeSH Term)
  • Alcuronium (MeSH Term)
  • Atracurium (MeSH Term)
  • Ethidium (MeSH Term)
  • Chlorisondamine (MeSH Term)
  • Trimethaphan (MeSH Term)
  • Tubocurarine (MeSH Term)
  • Vecuronium Bromide (MeSH Term)
  • Paraoxon (MeSH Term)
  • Parathion (MeSH Term)
  • Tacrine (MeSH Term)
  • Tetrachlorvinphos (MeSH Term)
  • Tetraisopropylpyrophosphamide (MeSH Term)
  • Rivastigmine (MeSH Term)
  • Isoflurophate (MeSH Term)
  • Malathion (MeSH Term)
  • Pyridostigmine Bromide (MeSH Term)
  • Diazinon (MeSH Term)
  • Dichlorvos (MeSH Term)
  • Naled (MeSH Term)
  • Neostigmine (MeSH Term)
  • Coumaphos (MeSH Term)
  • Fenitrothion (MeSH Term)
  • Fenthion (MeSH Term)
  • Galantamine (MeSH Term)
  • Aldicarb (MeSH Term)
  • Ambenonium Chloride (MeSH Term)
  • Propoxur (MeSH Term)
  • Armin (MeSH Term)
  • Azinphosmethyl (MeSH Term)
  • Carbofuran (MeSH Term)
  • Mevinphos (MeSH Term)
  • Monocrotophos (MeSH Term)
  • Sarin (MeSH Term)
  • Carbaryl (MeSH Term)
  • Soman (MeSH Term)
  • Dimethoate (MeSH Term)
  • Chlorpyrifos (MeSH Term)
  • Fonofos (MeSH Term)
  • Echothiophate Iodide (MeSH Term)
  • Edrophonium (MeSH Term)
  • Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester (MeSH Term)
  • Chlorfenvinphos (MeSH Term)
  • Trichlorfon (MeSH Term)
  • Methomyl (MeSH Term)
  • Methyl Parathion (MeSH Term)
  • Phorate (MeSH Term)
  • Phosphamidon (MeSH Term)
  • Physostigmine (MeSH Term)
  • Donepezil (MeSH Term)
  • Obidoxime Chloride (MeSH Term)
  • Trimedoxime (MeSH Term)
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MeSH Term)
  • Duloxetine Hydrochloride (MeSH Term)
  • Levodopa (MeSH Term)
  • Memantine (MeSH Term)
  • Benserazide (MeSH Term)
  • Fusaric Acid (MeSH Term)
  • Amantadine (MeSH Term)
  • Carbidopa (MeSH Term)
  • Dihydroxyphenylalanine (MeSH Term)
  • Dopamine (MeSH Term)
  • Dexpramipexole (MeSH Term)
  • 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine (MeSH Term)
  • Pergolide (MeSH Term)
  • Aripiprazole (MeSH Term)
  • Lisuride (MeSH Term)
  • Dihydroergotamine (MeSH Term)
  • Bromocriptine (MeSH Term)
  • Fenoldopam (MeSH Term)
  • Quinpirole (MeSH Term)
  • Apomorphine (MeSH Term)
  • Dihydroergocornine (MeSH Term)
  • Dihydroergocryptine (MeSH Term)
  • Metergoline (MeSH Term)
  • Piribedil (MeSH Term)
  • Cabergoline (MeSH Term)
  • Pramipexole (MeSH Term)
  • Butaclamol (MeSH Term)
  • Penfluridol (MeSH Term)
  • Perazine (MeSH Term)
  • Perphenazine (MeSH Term)
  • Thiethylperazine (MeSH Term)
  • Thioridazine (MeSH Term)
  • Thiothixene (MeSH Term)
  • Acepromazine (MeSH Term)
  • Loxapine (MeSH Term)
  • Prochlorperazine (MeSH Term)
  • Promazine (MeSH Term)
  • Benperidol (MeSH Term)
  • Remoxipride (MeSH Term)
  • Risperidone (MeSH Term)
  • Clopenthixol (MeSH Term)
  • Raclopride (MeSH Term)
  • Flupenthixol (MeSH Term)
  • Fluphenazine (MeSH Term)
  • Fluspirilene (MeSH Term)
  • Azaperone (MeSH Term)
  • Spiperone (MeSH Term)
  • Sulpiride (MeSH Term)
  • Domperidone (MeSH Term)
  • Haloperidol (MeSH Term)
  • Chlorpromazine (MeSH Term)
  • Chlorprothixene (MeSH Term)
  • Trifluoperazine (MeSH Term)
  • Trifluperidol (MeSH Term)
  • Triflupromazine (MeSH Term)
  • Tiapride Hydrochloride (MeSH Term)
  • Mesoridazine (MeSH Term)
  • Methotrimeprazine (MeSH Term)
  • Pimozide (MeSH Term)
  • Amisulpride (MeSH Term)
  • Paliperidone Palmitate (MeSH Term)
  • Metoclopramide (MeSH Term)
  • Droperidol (MeSH Term)
  • Lisdexamfetamine Dimesylate (MeSH Term)
  • Dextroamphetamine (MeSH Term)
  • Nomifensine (MeSH Term)
  • Cocaine (MeSH Term)
  • Methylphenidate (MeSH Term)
  • Dexmethylphenidate Hydrochloride (MeSH Term)
  • Bupropion (MeSH Term)
  • N-Methylaspartate (MeSH Term)
  • Quisqualic Acid (MeSH Term)
  • Kainic Acid (MeSH Term)
  • alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (MeSH Term)
  • Ibotenic Acid (MeSH Term)
  • 2-Amino-5-phosphonovalerate (MeSH Term)
  • Dizocilpine Maleate (MeSH Term)
  • Ketamine (MeSH Term)
  • Kynurenic Acid (MeSH Term)
  • Dextromethorphan (MeSH Term)
  • Dextrorphan (MeSH Term)
  • 6-Cyano-7-nitroquinoxaline-2,3-dione (MeSH Term)
  • Riluzole (MeSH Term)
  • Ibogaine (MeSH Term)
  • 2-Aminoadipic Acid (MeSH Term)
  • Phencyclidine (MeSH Term)
  • Phenobarbital (MeSH Term)
  • Gabapentin (MeSH Term)
  • Felbamate (MeSH Term)
  • Vigabatrin (MeSH Term)
  • gamma-Aminobutyric Acid (MeSH Term)
  • Aminooxyacetic Acid (MeSH Term)
  • Valproic Acid (MeSH Term)
  • 3-Mercaptopropionic Acid (MeSH Term)
  • Muscimol (MeSH Term)
  • Zolpidem (MeSH Term)
  • Clobazam (MeSH Term)
  • Baclofen (MeSH Term)
  • Pentylenetetrazole (MeSH Term)
  • Clozapine (MeSH Term)
  • Allylglycine (MeSH Term)
  • Bicuculline (MeSH Term)
  • Picrotoxin (MeSH Term)
  • Pentobarbital (MeSH Term)
  • Temazepam (MeSH Term)
  • Thiamylal (MeSH Term)
  • Thiopental (MeSH Term)
  • Lorazepam (MeSH Term)
  • Medazepam (MeSH Term)
  • Mephobarbital (MeSH Term)
  • Prazepam (MeSH Term)
  • Primidone (MeSH Term)
  • Nordazepam (MeSH Term)
  • Diazepam (MeSH Term)
  • Nitrazepam (MeSH Term)
  • Oxazepam (MeSH Term)
  • Bromazepam (MeSH Term)
  • Clonazepam (MeSH Term)
  • Clorazepate Dipotassium (MeSH Term)
  • Flumazenil (MeSH Term)
  • Flunitrazepam (MeSH Term)
  • Flurazepam (MeSH Term)
  • Alprazolam (MeSH Term)
  • Amobarbital (MeSH Term)
  • Barbital (MeSH Term)
  • Midazolam (MeSH Term)
  • Secobarbital (MeSH Term)
  • Estazolam (MeSH Term)
  • Hexobarbital (MeSH Term)
  • Chlordiazepoxide (MeSH Term)
  • Chlormethiazole (MeSH Term)
  • Triazolam (MeSH Term)
  • Zolazepam (MeSH Term)
  • Tiagabine (MeSH Term)
  • Carbon Monoxide (MeSH Term)
  • Hydrogen Sulfide (MeSH Term)
  • Glycine (MeSH Term)
  • Strychnine (MeSH Term)
  • Betahistine (MeSH Term)
  • Betazole (MeSH Term)
  • Dimaprit (MeSH Term)
  • Impromidine (MeSH Term)
  • Histamine (MeSH Term)
  • Butyric Acid (MeSH Term)
  • Doxepin (MeSH Term)
  • Ketotifen (MeSH Term)
  • Promethazine (MeSH Term)
  • Pyrilamine (MeSH Term)
  • Brompheniramine (MeSH Term)
  • Clemastine (MeSH Term)
  • Cyclizine (MeSH Term)
  • Cyproheptadine (MeSH Term)
  • Flunarizine (MeSH Term)
  • Antazoline (MeSH Term)
  • Dimenhydrinate (MeSH Term)
  • Dimethindene (MeSH Term)
  • Diphenhydramine (MeSH Term)
  • Doxylamine (MeSH Term)
  • Hydroxyzine (MeSH Term)
  • Chlorpheniramine (MeSH Term)
  • Cinnarizine (MeSH Term)
  • Tripelennamine (MeSH Term)
  • Triprolidine (MeSH Term)
  • Methapyrilene (MeSH Term)
  • Pheniramine (MeSH Term)
  • Olopatadine Hydrochloride (MeSH Term)
  • Cetirizine (MeSH Term)
  • Loratadine (MeSH Term)
  • Astemizole (MeSH Term)
  • Terfenadine (MeSH Term)
  • Burimamide (MeSH Term)
  • Famotidine (MeSH Term)
  • Metiamide (MeSH Term)
  • Ranitidine (MeSH Term)
  • Cimetidine (MeSH Term)
  • Nizatidine (MeSH Term)
  • Aprepitant (MeSH Term)
  • Desvenlafaxine Succinate (MeSH Term)
  • Venlafaxine Hydrochloride (MeSH Term)
  • Milnacipran (MeSH Term)
  • Levomilnacipran (MeSH Term)
  • Citalopram (MeSH Term)
  • Trazodone (MeSH Term)
  • Vilazodone Hydrochloride (MeSH Term)
  • Norfenfluramine (MeSH Term)
  • Paroxetine (MeSH Term)
  • Clomipramine (MeSH Term)
  • Sertraline (MeSH Term)
  • Fenfluramine (MeSH Term)
  • Fluoxetine (MeSH Term)
  • Zimeldine (MeSH Term)
  • Olanzapine (MeSH Term)
  • Fluvoxamine (MeSH Term)
  • Vortioxetine (MeSH Term)
  • Escitalopram (MeSH Term)
  • Adenosine (MeSH Term)
  • Caffeine (MeSH Term)
  • Theophylline (MeSH Term)
  • Aminophylline (MeSH Term)
  • Ticlopidine (MeSH Term)
  • Clopidogrel (MeSH Term)
  • Ticagrelor (MeSH Term)
  • p-Chloroamphetamine (MeSH Term)
  • 5,6-Dihydroxytryptamine (MeSH Term)
  • 5,7-Dihydroxytryptamine (MeSH Term)
  • Buspirone (MeSH Term)
  • Lysergic Acid Diethylamide (MeSH Term)
  • 8-Hydroxy-2-(di-n-propylamino)tetralin (MeSH Term)
  • Cisapride (MeSH Term)
  • Dexfenfluramine (MeSH Term)
  • Quipazine (MeSH Term)
  • Serotonin (MeSH Term)
  • N,N-Dimethyltryptamine (MeSH Term)
  • DOM 2,5-Dimethoxy-4-Methylamphetamine (MeSH Term)
  • Mescaline (MeSH Term)
  • Sumatriptan (MeSH Term)
  • Fenclonine (MeSH Term)
  • Ketanserin (MeSH Term)
  • Nafronyl (MeSH Term)
  • Bufotenin (MeSH Term)
  • Methysergide (MeSH Term)
  • Cinanserin (MeSH Term)
  • Methiothepin (MeSH Term)
  • Pizotyline (MeSH Term)
  • Ritanserin (MeSH Term)
  • Ondansetron (MeSH Term)
  • Granisetron (MeSH Term)
  • Palonosetron (MeSH Term)
  • Tropisetron (MeSH Term)

Supplemental Content

Loading ...